Summary
Structures and Sequence Alignment
The best structural homolog that predicted by 1. PB was
O00241
(Signal-regulatory protein beta-1) with a FATCAT P-Value: 0.0 and RMSD of 2.61 angstrom. The sequence alignment identity is 87.5%.
Structural alignment shown in left. Query protein Q5TFQ8 colored as red in alignment, homolog O00241 colored as blue.
Query protein Q5TFQ8 is also shown in right top, homolog O00241 showed in right bottom. They are colored based on secondary structures.
Q5TFQ8 MPVPASWPHLPSPFLLMTLLLGRLTGVAGEEELQVIQPDKSISVAAGESATLHCTVTSLIPVGPIQWFRGAGPGRELIYNQKEGHFPRVTTVSDLTKRNN 100 O00241 MPVPASWPHLPSPFLLMTLLLGRLTGVAGEDELQVIQPEKSVSVAAGESATLRCAMTSLIPVGPIMWFRGAGAGRELIYNQKEGHFPRVTTVSELTKRNN 100 Q5TFQ8 MDFSIRISNITPADAGTYYCVKFRKGSPDHVEFKSGAGTELSVRAKPSAPVVSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPA 200 O00241 LDFSISISNITPADAGTYYCVKFRKGSPDDVEFKSGAGTELSVRAKPSAPVVSGPAVRATPEHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPA 200 Q5TFQ8 GDSVSYSIHSTAKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETAST 300 O00241 GDSVSYSIHSTARVVLTRGDVHSQVICEIAHITLQGDPLRGTANLSEAIRVPPTLEVTQQPMRAENQANVTCQVSNFYPRGLQLTWLENGNVSRTETAST 300 Q5TFQ8 LTENKDGTYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSAHPKEQGSN-TAPGPALASAAPLLIAFLLGPKVLLVVGVSVIYVYWKQKA 398 O00241 LIENKDGTYNWMSWLLVNTCAHRDDVVLTCQVEHDGQQAVSKSYALEISAHQKEHGSDITHEA-ALAPTAPLLVALLLGPKLLLVVGVSAIYICWKQKA 398
Go Annotations
1. PB indicates the go terms that are found by both PROST and BLAST.2. P indicates the go terms that are found by only PROST.
3. B indicates the go terms that are only annotated by BLAST.
Source | GO | Description |
---|---|---|
1. PB | GO:0071281 | cellular response to iron ion |
1. PB | GO:0042277 | peptide binding |
1. PB | GO:0071346 | cellular response to interferon-gamma |
1. PB | GO:0046007 | negative regulation of activated T cell proliferation |
1. PB | GO:0033010 | paranodal junction |
1. PB | GO:0001815 | positive regulation of antibody-dependent cellular cytotoxicity |
1. PB | GO:0019226 | transmission of nerve impulse |
1. PB | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
1. PB | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
1. PB | GO:0032720 | negative regulation of tumor necrosis factor production |
1. PB | GO:0042608 | T cell receptor binding |
1. PB | GO:0071593 | lymphocyte aggregation |
1. PB | GO:0032673 | regulation of interleukin-4 production |
1. PB | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib |
1. PB | GO:0045178 | basal part of cell |
1. PB | GO:0046979 | TAP2 binding |
1. PB | GO:0010106 | cellular response to iron ion starvation |
1. PB | GO:0036037 | CD8-positive, alpha-beta T cell activation |
1. PB | GO:0010039 | response to iron ion |
1. PB | GO:1990782 | protein tyrosine kinase binding |
1. PB | GO:0010008 | endosome membrane |
1. PB | GO:0098880 | maintenance of postsynaptic specialization structure |
1. PB | GO:0042446 | hormone biosynthetic process |
1. PB | GO:1901215 | negative regulation of neuron death |
1. PB | GO:0001819 | positive regulation of cytokine production |
1. PB | GO:0050860 | negative regulation of T cell receptor signaling pathway |
1. PB | GO:0030424 | axon |
1. PB | GO:0042610 | CD8 receptor binding |
1. PB | GO:0002250 | adaptive immune response |
1. PB | GO:0031902 | late endosome membrane |
1. PB | GO:0030669 | clathrin-coated endocytic vesicle membrane |
1. PB | GO:0002503 | peptide antigen assembly with MHC class II protein complex |
1. PB | GO:0050778 | positive regulation of immune response |
1. PB | GO:0032759 | positive regulation of TRAIL production |
1. PB | GO:0001913 | T cell mediated cytotoxicity |
1. PB | GO:0003823 | antigen binding |
1. PB | GO:0032743 | positive regulation of interleukin-2 production |
1. PB | GO:2000273 | positive regulation of signaling receptor activity |
1. PB | GO:0005911 | cell-cell junction |
1. PB | GO:0023026 | MHC class II protein complex binding |
1. PB | GO:0044877 | protein-containing complex binding |
1. PB | GO:0001812 | positive regulation of type I hypersensitivity |
1. PB | GO:0032729 | positive regulation of interferon-gamma production |
1. PB | GO:0019903 | protein phosphatase binding |
1. PB | GO:0099054 | presynapse assembly |
1. PB | GO:0042288 | MHC class I protein binding |
1. PB | GO:1900016 | negative regulation of cytokine production involved in inflammatory response |
1. PB | GO:0031901 | early endosome membrane |
1. PB | GO:0032398 | MHC class Ib protein complex |
1. PB | GO:0006959 | humoral immune response |
1. PB | GO:1900121 | negative regulation of receptor binding |
1. PB | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane |
1. PB | GO:1990641 | response to iron ion starvation |
1. PB | GO:0045019 | negative regulation of nitric oxide biosynthetic process |
1. PB | GO:0098636 | protein complex involved in cell adhesion |
1. PB | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent |
1. PB | GO:0002451 | peripheral B cell tolerance induction |
1. PB | GO:0005615 | extracellular space |
1. PB | GO:0002626 | negative regulation of T cell antigen processing and presentation |
1. PB | GO:0009986 | cell surface |
1. PB | GO:0002344 | B cell affinity maturation |
1. PB | GO:0050689 | negative regulation of defense response to virus by host |
1. PB | GO:0042110 | T cell activation |
1. PB | GO:0032680 | regulation of tumor necrosis factor production |
1. PB | GO:0030695 | GTPase regulator activity |
1. PB | GO:0009897 | external side of plasma membrane |
1. PB | GO:0090277 | positive regulation of peptide hormone secretion |
1. PB | GO:0010770 | positive regulation of cell morphogenesis involved in differentiation |
1. PB | GO:0005737 | cytoplasm |
1. PB | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor |
1. PB | GO:0001916 | positive regulation of T cell mediated cytotoxicity |
1. PB | GO:0032653 | regulation of interleukin-10 production |
1. PB | GO:0050766 | positive regulation of phagocytosis |
1. PB | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
1. PB | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation |
1. PB | GO:0070593 | dendrite self-avoidance |
1. PB | GO:0010977 | negative regulation of neuron projection development |
1. PB | GO:0016323 | basolateral plasma membrane |
1. PB | GO:0008037 | cell recognition |
1. PB | GO:0032753 | positive regulation of interleukin-4 production |
1. PB | GO:0070062 | extracellular exosome |
1. PB | GO:0019884 | antigen processing and presentation of exogenous antigen |
1. PB | GO:0006955 | immune response |
1. PB | GO:0006910 | phagocytosis, recognition |
1. PB | GO:0042101 | T cell receptor complex |
1. PB | GO:0002579 | positive regulation of antigen processing and presentation |
1. PB | GO:0001798 | positive regulation of type IIa hypersensitivity |
1. PB | GO:0002728 | negative regulation of natural killer cell cytokine production |
1. PB | GO:0002486 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
1. PB | GO:0062061 | TAP complex binding |
1. PB | GO:0030881 | beta-2-microglobulin binding |
1. PB | GO:0051606 | detection of stimulus |
1. PB | GO:0030658 | transport vesicle membrane |
1. PB | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
1. PB | GO:0097021 | lymphocyte migration into lymphoid organs |
1. PB | GO:0042130 | negative regulation of T cell proliferation |
1. PB | GO:0060586 | multicellular organismal iron ion homeostasis |
1. PB | GO:0002469 | myeloid dendritic cell antigen processing and presentation |
1. PB | GO:0046635 | positive regulation of alpha-beta T cell activation |
1. PB | GO:0005886 | plasma membrane |
1. PB | GO:0006911 | phagocytosis, engulfment |
1. PB | GO:0034987 | immunoglobulin receptor binding |
1. PB | GO:0055038 | recycling endosome membrane |
1. PB | GO:0043322 | negative regulation of natural killer cell degranulation |
1. PB | GO:0007520 | myoblast fusion |
1. PB | GO:0101003 | ficolin-1-rich granule membrane |
1. PB | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation |
1. PB | GO:0071349 | cellular response to interleukin-12 |
1. PB | GO:0002854 | positive regulation of T cell mediated cytotoxicity directed against tumor cell target |
1. PB | GO:0045087 | innate immune response |
1. PB | GO:0019864 | IgG binding |
1. PB | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
1. PB | GO:0002715 | regulation of natural killer cell mediated immunity |
1. PB | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity |
1. PB | GO:0032588 | trans-Golgi network membrane |
1. PB | GO:0071222 | cellular response to lipopolysaccharide |
1. PB | GO:1990405 | protein antigen binding |
1. PB | GO:1904437 | positive regulation of transferrin receptor binding |
1. PB | GO:0042824 | MHC class I peptide loading complex |
1. PB | GO:0050765 | negative regulation of phagocytosis |
1. PB | GO:0019882 | antigen processing and presentation |
1. PB | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell |
1. PB | GO:0048002 | antigen processing and presentation of peptide antigen |
1. PB | GO:0048839 | inner ear development |
1. PB | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
1. PB | GO:0007411 | axon guidance |
1. PB | GO:0002455 | humoral immune response mediated by circulating immunoglobulin |
1. PB | GO:0046703 | natural killer cell lectin-like receptor binding |
1. PB | GO:0050870 | positive regulation of T cell activation |
1. PB | GO:0071347 | cellular response to interleukin-1 |
1. PB | GO:0042605 | peptide antigen binding |
1. PB | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation |
1. PB | GO:0097530 | granulocyte migration |
1. PB | GO:0002491 | antigen processing and presentation of endogenous peptide antigen via MHC class II |
1. PB | GO:0030670 | phagocytic vesicle membrane |
1. PB | GO:0071650 | negative regulation of chemokine (C-C motif) ligand 5 production |
1. PB | GO:0031295 | T cell costimulation |
1. PB | GO:0005102 | signaling receptor binding |
1. PB | GO:0042613 | MHC class II protein complex |
1. PB | GO:0097241 | hematopoietic stem cell migration to bone marrow |
1. PB | GO:0070301 | cellular response to hydrogen peroxide |
1. PB | GO:0002645 | positive regulation of tolerance induction |
1. PB | GO:1904283 | negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I |
1. PB | GO:0001562 | response to protozoan |
1. PB | GO:0045123 | cellular extravasation |
1. PB | GO:1900122 | positive regulation of receptor binding |
1. PB | GO:0033268 | node of Ranvier |
1. PB | GO:2000272 | negative regulation of signaling receptor activity |
1. PB | GO:0002355 | detection of tumor cell |
1. PB | GO:2001199 | negative regulation of dendritic cell differentiation |
1. PB | GO:0002729 | positive regulation of natural killer cell cytokine production |
1. PB | GO:0045428 | regulation of nitric oxide biosynthetic process |
1. PB | GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process |
1. PB | GO:0098942 | retrograde trans-synaptic signaling by trans-synaptic protein complex |
1. PB | GO:0032715 | negative regulation of interleukin-6 production |
1. PB | GO:0071641 | negative regulation of macrophage inflammatory protein 1 alpha production |
1. PB | GO:0050852 | T cell receptor signaling pathway |
1. PB | GO:0045309 | protein phosphorylated amino acid binding |
1. PB | GO:0005634 | nucleus |
1. PB | GO:0035696 | monocyte extravasation |
1. PB | GO:0048260 | positive regulation of receptor-mediated endocytosis |
1. PB | GO:2000403 | positive regulation of lymphocyte migration |
1. PB | GO:0007166 | cell surface receptor signaling pathway |
1. PB | GO:0006958 | complement activation, classical pathway |
1. PB | GO:0046329 | negative regulation of JNK cascade |
1. PB | GO:0016064 | immunoglobulin mediated immune response |
1. PB | GO:0050853 | B cell receptor signaling pathway |
1. PB | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II |
1. PB | GO:0070971 | endoplasmic reticulum exit site |
1. PB | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion |
1. PB | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
1. PB | GO:0032651 | regulation of interleukin-1 beta production |
1. PB | GO:0002859 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
1. PB | GO:0042270 | protection from natural killer cell mediated cytotoxicity |
1. PB | GO:0032675 | regulation of interleukin-6 production |
1. PB | GO:1990357 | terminal web |
1. PB | GO:1990712 | HFE-transferrin receptor complex |
1. PB | GO:0001817 | regulation of cytokine production |
1. PB | GO:0007155 | cell adhesion |
1. PB | GO:0098711 | iron ion import across plasma membrane |
1. PB | GO:0001772 | immunological synapse |
1. PB | GO:0005765 | lysosomal membrane |
1. PB | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity |
1. PB | GO:0050868 | negative regulation of T cell activation |
1. PB | GO:0032819 | positive regulation of natural killer cell proliferation |
1. PB | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I |
1. PB | GO:0019770 | IgG receptor activity |
1. PB | GO:0005771 | multivesicular body |
1. PB | GO:0032395 | MHC class II receptor activity |
1. PB | GO:0015026 | coreceptor activity |
1. PB | GO:1904434 | positive regulation of ferrous iron binding |
1. PB | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent |
1. PB | GO:0001788 | antibody-dependent cellular cytotoxicity |
1. PB | GO:0005769 | early endosome |
1. PB | GO:0042102 | positive regulation of T cell proliferation |
1. PB | GO:0032736 | positive regulation of interleukin-13 production |
1. PB | GO:0034341 | response to interferon-gamma |
1. PB | GO:0032649 | regulation of interferon-gamma production |
1. PB | GO:0002639 | positive regulation of immunoglobulin production |
1. PB | GO:0050839 | cell adhesion molecule binding |
1. PB | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity |
1. PB | GO:0005794 | Golgi apparatus |
1. PB | GO:0039706 | co-receptor binding |
1. PB | GO:0016021 | integral component of membrane |
1. PB | GO:0045622 | regulation of T-helper cell differentiation |
1. PB | GO:0042612 | MHC class I protein complex |
1. PB | GO:2000008 | regulation of protein localization to cell surface |
1. PB | GO:0046629 | gamma-delta T cell activation |
1. PB | GO:1990459 | transferrin receptor binding |
1. PB | GO:0034756 | regulation of iron ion transport |
1. PB | GO:0046977 | TAP binding |
1. PB | GO:0002725 | negative regulation of T cell cytokine production |
1. PB | GO:0036057 | slit diaphragm |
1. PB | GO:0030666 | endocytic vesicle membrane |
1. PB | GO:1903720 | negative regulation of I-kappaB phosphorylation |
1. PB | GO:0005829 | cytosol |
1. PB | GO:0032809 | neuronal cell body membrane |
1. PB | GO:0030667 | secretory granule membrane |
1. PB | GO:0098609 | cell-cell adhesion |
1. PB | GO:0033077 | T cell differentiation in thymus |
1. PB | GO:0012507 | ER to Golgi transport vesicle membrane |
1. PB | GO:0032688 | negative regulation of interferon-beta production |
1. PB | GO:0002419 | T cell mediated cytotoxicity directed against tumor cell target |
1. PB | GO:0005797 | Golgi medial cisterna |
1. PB | GO:0001933 | negative regulation of protein phosphorylation |
1. PB | GO:0098632 | cell-cell adhesion mediator activity |
1. PB | GO:0000139 | Golgi membrane |
1. PB | GO:0002399 | MHC class II protein complex assembly |
1. PB | GO:0002429 | immune response-activating cell surface receptor signaling pathway |
1. PB | GO:0016045 | detection of bacterium |
1. PB | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I |
1. PB | GO:0002519 | natural killer cell tolerance induction |
1. PB | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway |
1. PB | GO:0002717 | positive regulation of natural killer cell mediated immunity |
2. P | GO:1903753 | negative regulation of p38MAPK cascade |
2. P | GO:0045591 | positive regulation of regulatory T cell differentiation |
2. P | GO:1903387 | positive regulation of homophilic cell adhesion |
2. P | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway |
2. P | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process |
2. P | GO:0002457 | T cell antigen processing and presentation |
2. P | GO:0015125 | bile acid transmembrane transporter activity |
2. P | GO:0150076 | neuroinflammatory response |
2. P | GO:0005244 | voltage-gated ion channel activity |
2. P | GO:0098640 | integrin binding involved in cell-matrix adhesion |
2. P | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity |
2. P | GO:0042088 | T-helper 1 type immune response |
2. P | GO:0002438 | acute inflammatory response to antigenic stimulus |
2. P | GO:0023035 | CD40 signaling pathway |
2. P | GO:0010477 | response to sulfur dioxide |
2. P | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization |
2. P | GO:0070372 | regulation of ERK1 and ERK2 cascade |
2. P | GO:0019863 | IgE binding |
2. P | GO:0046684 | response to pyrethroid |
2. P | GO:0034181 | positive regulation of toll-like receptor 13 signaling pathway |
2. P | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway |
2. P | GO:0008038 | neuron recognition |
2. P | GO:1904466 | positive regulation of matrix metallopeptidase secretion |
2. P | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway |
2. P | GO:0050900 | leukocyte migration |
2. P | GO:0070571 | negative regulation of neuron projection regeneration |
2. P | GO:0010460 | positive regulation of heart rate |
2. P | GO:0030054 | cell junction |
2. P | GO:0038158 | granulocyte colony-stimulating factor signaling pathway |
2. P | GO:0010765 | positive regulation of sodium ion transport |
2. P | GO:0002819 | regulation of adaptive immune response |
2. P | GO:0033629 | negative regulation of cell adhesion mediated by integrin |
2. P | GO:0032690 | negative regulation of interleukin-1 alpha production |
2. P | GO:2001214 | positive regulation of vasculogenesis |
2. P | GO:0072659 | protein localization to plasma membrane |
2. P | GO:0086015 | SA node cell action potential |
2. P | GO:0050867 | positive regulation of cell activation |
2. P | GO:0035725 | sodium ion transmembrane transport |
2. P | GO:0042104 | positive regulation of activated T cell proliferation |
2. P | GO:0019966 | interleukin-1 binding |
2. P | GO:0071312 | cellular response to alkaloid |
2. P | GO:0030889 | negative regulation of B cell proliferation |
2. P | GO:0035581 | sequestering of extracellular ligand from receptor |
2. P | GO:2000439 | positive regulation of monocyte extravasation |
2. P | GO:0005537 | mannose binding |
2. P | GO:0005784 | Sec61 translocon complex |
2. P | GO:0097197 | tetraspanin-enriched microdomain |
2. P | GO:0042105 | alpha-beta T cell receptor complex |
2. P | GO:1905449 | regulation of Fc-gamma receptor signaling pathway involved in phagocytosis |
2. P | GO:0014911 | positive regulation of smooth muscle cell migration |
2. P | GO:0042734 | presynaptic membrane |
2. P | GO:0071354 | cellular response to interleukin-6 |
2. P | GO:0070392 | detection of lipoteichoic acid |
2. P | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell |
2. P | GO:0002922 | positive regulation of humoral immune response |
2. P | GO:0055036 | virion membrane |
2. P | GO:0150104 | transport across blood-brain barrier |
2. P | GO:0045065 | cytotoxic T cell differentiation |
2. P | GO:0019772 | low-affinity IgG receptor activity |
2. P | GO:1900273 | positive regulation of long-term synaptic potentiation |
2. P | GO:0004908 | interleukin-1 receptor activity |
2. P | GO:0002080 | acrosomal membrane |
2. P | GO:1905805 | excitatory synapse pruning |
2. P | GO:0150072 | positive regulation of arginase activity |
2. P | GO:0002079 | inner acrosomal membrane |
2. P | GO:1903385 | regulation of homophilic cell adhesion |
2. P | GO:0120035 | regulation of plasma membrane bounded cell projection organization |
2. P | GO:0005887 | integral component of plasma membrane |
2. P | GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
2. P | GO:0005764 | lysosome |
2. P | GO:0042007 | interleukin-18 binding |
2. P | GO:0005178 | integrin binding |
2. P | GO:0050892 | intestinal absorption |
2. P | GO:0032735 | positive regulation of interleukin-12 production |
2. P | GO:0044325 | transmembrane transporter binding |
2. P | GO:0051055 | negative regulation of lipid biosynthetic process |
2. P | GO:2000145 | regulation of cell motility |
2. P | GO:0030293 | transmembrane receptor protein tyrosine kinase inhibitor activity |
2. P | GO:0034351 | negative regulation of glial cell apoptotic process |
2. P | GO:0050863 | regulation of T cell activation |
2. P | GO:0032692 | negative regulation of interleukin-1 production |
2. P | GO:0002845 | positive regulation of tolerance induction to tumor cell |
2. P | GO:0090264 | regulation of immune complex clearance by monocytes and macrophages |
2. P | GO:0071723 | lipopeptide binding |
2. P | GO:0050850 | positive regulation of calcium-mediated signaling |
2. P | GO:0045494 | photoreceptor cell maintenance |
2. P | GO:1905808 | positive regulation of synapse pruning |
2. P | GO:0044291 | cell-cell contact zone |
2. P | GO:2000509 | negative regulation of dendritic cell chemotaxis |
2. P | GO:1900272 | negative regulation of long-term synaptic potentiation |
2. P | GO:0150102 | negative regulation of monocyte activation |
2. P | GO:0060312 | regulation of blood vessel remodeling |
2. P | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
2. P | GO:0002273 | plasmacytoid dendritic cell differentiation |
2. P | GO:0098657 | import into cell |
2. P | GO:0032393 | MHC class I receptor activity |
2. P | GO:0035579 | specific granule membrane |
2. P | GO:0086012 | membrane depolarization during cardiac muscle cell action potential |
2. P | GO:1903980 | positive regulation of microglial cell activation |
2. P | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
2. P | GO:0070379 | high mobility group box 1 binding |
2. P | GO:0019763 | immunoglobulin receptor activity |
2. P | GO:0002410 | plasmacytoid dendritic cell chemotaxis |
2. P | GO:0051493 | regulation of cytoskeleton organization |
2. P | GO:0021966 | corticospinal neuron axon guidance |
2. P | GO:0032691 | negative regulation of interleukin-1 beta production |
2. P | GO:1902950 | regulation of dendritic spine maintenance |
2. P | GO:0022614 | membrane to membrane docking |
2. P | GO:0007167 | enzyme linked receptor protein signaling pathway |
2. P | GO:1901143 | insulin catabolic process |
2. P | GO:0002693 | positive regulation of cellular extravasation |
2. P | GO:0038065 | collagen-activated signaling pathway |
2. P | GO:0019227 | neuronal action potential propagation |
2. P | GO:0042011 | interleukin-16 binding |
2. P | GO:0006469 | negative regulation of protein kinase activity |
2. P | GO:0045577 | regulation of B cell differentiation |
2. P | GO:0042012 | interleukin-16 receptor activity |
2. P | GO:0010976 | positive regulation of neuron projection development |
2. P | GO:0031941 | filamentous actin |
2. P | GO:0071333 | cellular response to glucose stimulus |
2. P | GO:0005902 | microvillus |
2. P | GO:0030110 | HLA-C specific inhibitory MHC class I receptor activity |
2. P | GO:0038160 | CXCL12-activated CXCR4 signaling pathway |
2. P | GO:0044319 | wound healing, spreading of cells |
2. P | GO:0032966 | negative regulation of collagen biosynthetic process |
2. P | GO:0034698 | response to gonadotropin |
2. P | GO:0001774 | microglial cell activation |
2. P | GO:0031642 | negative regulation of myelination |
2. P | GO:0061154 | endothelial tube morphogenesis |
2. P | GO:0019865 | immunoglobulin binding |
2. P | GO:0090383 | phagosome acidification |
2. P | GO:0034157 | positive regulation of toll-like receptor 7 signaling pathway |
2. P | GO:1905522 | negative regulation of macrophage migration |
2. P | GO:0002266 | follicular dendritic cell activation |
2. P | GO:0035683 | memory T cell extravasation |
2. P | GO:1900744 | regulation of p38MAPK cascade |
2. P | GO:0150079 | negative regulation of neuroinflammatory response |
2. P | GO:0071224 | cellular response to peptidoglycan |
2. P | GO:1904141 | positive regulation of microglial cell migration |
2. P | GO:0031005 | filamin binding |
2. P | GO:0097368 | establishment of Sertoli cell barrier |
2. P | GO:1902414 | protein localization to cell junction |
2. P | GO:0033691 | sialic acid binding |
2. P | GO:1904861 | excitatory synapse assembly |
2. P | GO:0019768 | high-affinity IgE receptor activity |
2. P | GO:0035577 | azurophil granule membrane |
2. P | GO:0010595 | positive regulation of endothelial cell migration |
2. P | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization |
2. P | GO:0004910 | interleukin-1, type II, blocking receptor activity |
2. P | GO:0051101 | regulation of DNA binding |
2. P | GO:0002891 | positive regulation of immunoglobulin mediated immune response |
2. P | GO:0010255 | glucose mediated signaling pathway |
2. P | GO:1904646 | cellular response to amyloid-beta |
2. P | GO:0033005 | positive regulation of mast cell activation |
2. P | GO:0043318 | negative regulation of cytotoxic T cell degranulation |
2. P | GO:1901980 | positive regulation of inward rectifier potassium channel activity |
2. P | GO:0045780 | positive regulation of bone resorption |
2. P | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential |
2. P | GO:0005105 | type 1 fibroblast growth factor receptor binding |
2. P | GO:0046813 | receptor-mediated virion attachment to host cell |
2. P | GO:0014704 | intercalated disc |
2. P | GO:0031528 | microvillus membrane |
2. P | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response |
2. P | GO:0033860 | regulation of NAD(P)H oxidase activity |
2. P | GO:0002313 | mature B cell differentiation involved in immune response |
2. P | GO:0019766 | IgA receptor activity |
2. P | GO:2000405 | negative regulation of T cell migration |
2. P | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
2. P | GO:0005130 | granulocyte colony-stimulating factor receptor binding |
2. P | GO:0038023 | signaling receptor activity |
2. P | GO:0150094 | amyloid-beta clearance by cellular catabolic process |
2. P | GO:0002436 | immune complex clearance by monocytes and macrophages |
2. P | GO:0030165 | PDZ domain binding |
2. P | GO:0043382 | positive regulation of memory T cell differentiation |
2. P | GO:0042289 | MHC class II protein binding |
2. P | GO:1905710 | positive regulation of membrane permeability |
2. P | GO:0001780 | neutrophil homeostasis |
2. P | GO:0010955 | negative regulation of protein processing |
2. P | GO:0001931 | uropod |
2. P | GO:1902623 | negative regulation of neutrophil migration |
2. P | GO:2000558 | positive regulation of immunoglobulin production in mucosal tissue |
2. P | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
2. P | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus |
2. P | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation |
2. P | GO:0001848 | complement binding |
2. P | GO:0005912 | adherens junction |
2. P | GO:0150062 | complement-mediated synapse pruning |
2. P | GO:2000352 | negative regulation of endothelial cell apoptotic process |
2. P | GO:0032499 | detection of peptidoglycan |
2. P | GO:0051497 | negative regulation of stress fiber assembly |
2. P | GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
2. P | GO:0032760 | positive regulation of tumor necrosis factor production |
2. P | GO:0045056 | transcytosis |
2. P | GO:0002446 | neutrophil mediated immunity |
2. P | GO:0051899 | membrane depolarization |
2. P | GO:0072683 | T cell extravasation |
2. P | GO:1901076 | positive regulation of engulfment of apoptotic cell |
2. P | GO:0035325 | Toll-like receptor binding |
2. P | GO:0045059 | positive thymic T cell selection |
2. P | GO:1903523 | negative regulation of blood circulation |
2. P | GO:0010884 | positive regulation of lipid storage |
2. P | GO:0072714 | response to selenite ion |
2. P | GO:0038016 | insulin receptor internalization |
2. P | GO:0061028 | establishment of endothelial barrier |
2. P | GO:0010822 | positive regulation of mitochondrion organization |
2. P | GO:0002220 | innate immune response activating cell surface receptor signaling pathway |
2. P | GO:1990051 | activation of protein kinase C activity |
2. P | GO:2000649 | regulation of sodium ion transmembrane transporter activity |
2. P | GO:0032497 | detection of lipopolysaccharide |
2. P | GO:0019767 | IgE receptor activity |
2. P | GO:0035726 | common myeloid progenitor cell proliferation |
2. P | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway |
2. P | GO:0002827 | positive regulation of T-helper 1 type immune response |
2. P | GO:0086005 | ventricular cardiac muscle cell action potential |
2. P | GO:0070352 | positive regulation of white fat cell proliferation |
2. P | GO:0150074 | positive regulation of protein-glutamine gamma-glutamyltransferase activity |
2. P | GO:0010891 | negative regulation of sequestering of triglyceride |
2. P | GO:0051926 | negative regulation of calcium ion transport |
2. P | GO:0051924 | regulation of calcium ion transport |
2. P | GO:0002318 | myeloid progenitor cell differentiation |
2. P | GO:0044406 | adhesion of symbiont to host |
2. P | GO:0002376 | immune system process |
2. P | GO:2001200 | positive regulation of dendritic cell differentiation |
2. P | GO:0050776 | regulation of immune response |
2. P | GO:0002523 | leukocyte migration involved in inflammatory response |
2. P | GO:0031362 | anchored component of external side of plasma membrane |
2. P | GO:2000346 | negative regulation of hepatocyte proliferation |
2. P | GO:0002588 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II |
2. P | GO:0045058 | T cell selection |
2. P | GO:0050823 | peptide antigen stabilization |
2. P | GO:0051963 | regulation of synapse assembly |
2. P | GO:0002232 | leukocyte chemotaxis involved in inflammatory response |
2. P | GO:0046978 | TAP1 binding |
2. P | GO:0044548 | S100 protein binding |
2. P | GO:0007159 | leukocyte cell-cell adhesion |
2. P | GO:1903142 | positive regulation of establishment of endothelial barrier |
2. P | GO:0050785 | advanced glycation end-product receptor activity |
2. P | GO:0010887 | negative regulation of cholesterol storage |
2. P | GO:0045959 | negative regulation of complement activation, classical pathway |
2. P | GO:0007286 | spermatid development |
2. P | GO:0042113 | B cell activation |
2. P | GO:0045960 | positive regulation of complement activation, classical pathway |
2. P | GO:1904472 | positive regulation of endothelin production |
2. P | GO:0001915 | negative regulation of T cell mediated cytotoxicity |
2. P | GO:1903209 | positive regulation of oxidative stress-induced cell death |
2. P | GO:0043184 | vascular endothelial growth factor receptor 2 binding |
2. P | GO:0045657 | positive regulation of monocyte differentiation |
2. P | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production |
2. P | GO:0001910 | regulation of leukocyte mediated cytotoxicity |
2. P | GO:0030101 | natural killer cell activation |
2. P | GO:0043183 | vascular endothelial growth factor receptor 1 binding |
2. P | GO:0090647 | modulation of age-related behavioral decline |
2. P | GO:1904951 | positive regulation of establishment of protein localization |
2. P | GO:0010594 | regulation of endothelial cell migration |
2. P | GO:0045582 | positive regulation of T cell differentiation |
2. P | GO:0001865 | NK T cell differentiation |
2. P | GO:0034260 | negative regulation of GTPase activity |
2. P | GO:0033627 | cell adhesion mediated by integrin |
2. P | GO:1902531 | regulation of intracellular signal transduction |
2. P | GO:0033084 | regulation of immature T cell proliferation in thymus |
2. P | GO:0048143 | astrocyte activation |
2. P | GO:0045916 | negative regulation of complement activation |
2. P | GO:0060370 | susceptibility to T cell mediated cytotoxicity |
2. P | GO:0060100 | positive regulation of phagocytosis, engulfment |
2. P | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization |
2. P | GO:0001813 | regulation of antibody-dependent cellular cytotoxicity |
2. P | GO:0039573 | suppression by virus of host complement activation |
2. P | GO:0032793 | positive regulation of CREB transcription factor activity |
2. P | GO:0045121 | membrane raft |
2. P | GO:0043549 | regulation of kinase activity |
2. P | GO:0034156 | negative regulation of toll-like receptor 7 signaling pathway |
2. P | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
2. P | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I |
2. P | GO:0002398 | MHC class Ib protein complex assembly |
2. P | GO:0050829 | defense response to Gram-negative bacterium |
2. P | GO:1904093 | negative regulation of autophagic cell death |
2. P | GO:0046697 | decidualization |
2. P | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production |
2. P | GO:0035879 | plasma membrane lactate transport |
2. P | GO:0038064 | collagen receptor activity |
2. P | GO:0030883 | endogenous lipid antigen binding |
2. P | GO:1905291 | positive regulation of CAMKK-AMPK signaling cascade |
2. P | GO:0070345 | negative regulation of fat cell proliferation |
2. P | GO:0140081 | glycosylated region protein binding |
2. P | GO:0034235 | GPI anchor binding |
2. P | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
2. P | GO:0070891 | lipoteichoic acid binding |
2. P | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation |
2. P | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
2. P | GO:0050866 | negative regulation of cell activation |
2. P | GO:0043116 | negative regulation of vascular permeability |
2. P | GO:0032693 | negative regulation of interleukin-10 production |
2. P | GO:0001791 | IgM binding |
2. P | GO:0045860 | positive regulation of protein kinase activity |
2. P | GO:0045576 | mast cell activation |
2. P | GO:1902683 | regulation of receptor localization to synapse |
2. P | GO:0005272 | sodium channel activity |
2. P | GO:0001618 | virus receptor activity |
2. P | GO:0060048 | cardiac muscle contraction |
2. P | GO:0034241 | positive regulation of macrophage fusion |
2. P | GO:0050777 | negative regulation of immune response |
2. P | GO:1905581 | positive regulation of low-density lipoprotein particle clearance |
2. P | GO:0002541 | activation of plasma proteins involved in acute inflammatory response |
2. P | GO:0007202 | activation of phospholipase C activity |
2. P | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production |
2. P | GO:1905404 | positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process |
2. P | GO:0002282 | microglial cell activation involved in immune response |
2. P | GO:0035723 | interleukin-15-mediated signaling pathway |
2. P | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis |
2. P | GO:0050930 | induction of positive chemotaxis |
2. P | GO:0039671 | evasion by virus of host natural killer cell activity |
2. P | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway |
2. P | GO:0001540 | amyloid-beta binding |
2. P | GO:0005055 | laminin receptor activity |
2. P | GO:0060077 | inhibitory synapse |
2. P | GO:0032752 | positive regulation of interleukin-3 production |
2. P | GO:1900271 | regulation of long-term synaptic potentiation |
2. P | GO:0043547 | positive regulation of GTPase activity |
2. P | GO:0061518 | microglial cell proliferation |
2. P | GO:0032507 | maintenance of protein location in cell |
2. P | GO:0007160 | cell-matrix adhesion |
2. P | GO:0030316 | osteoclast differentiation |
2. P | GO:0072657 | protein localization to membrane |
2. P | GO:0009925 | basal plasma membrane |
2. P | GO:0042119 | neutrophil activation |
2. P | GO:0070160 | tight junction |
2. P | GO:0033624 | negative regulation of integrin activation |
2. P | GO:0002765 | immune response-inhibiting signal transduction |
2. P | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
2. P | GO:1901216 | positive regulation of neuron death |
2. P | GO:1903376 | regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
2. P | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling |
2. P | GO:0005248 | voltage-gated sodium channel activity |
2. P | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production |
2. P | GO:0003723 | RNA binding |
2. P | GO:0098685 | Schaffer collateral - CA1 synapse |
2. P | GO:0034113 | heterotypic cell-cell adhesion |
2. P | GO:0030884 | exogenous lipid antigen binding |
2. P | GO:0060075 | regulation of resting membrane potential |
2. P | GO:0045728 | respiratory burst after phagocytosis |
2. P | GO:0042803 | protein homodimerization activity |
2. P | GO:0032731 | positive regulation of interleukin-1 beta production |
2. P | GO:0050901 | leukocyte tethering or rolling |
2. P | GO:0032689 | negative regulation of interferon-gamma production |
2. P | GO:0086014 | atrial cardiac muscle cell action potential |
2. P | GO:0030882 | lipid antigen binding |
2. P | GO:0008270 | zinc ion binding |
2. P | GO:0034189 | very-low-density lipoprotein particle binding |
2. P | GO:0061889 | negative regulation of astrocyte activation |
2. P | GO:0071813 | lipoprotein particle binding |
2. P | GO:0090022 | regulation of neutrophil chemotaxis |
2. P | GO:0030217 | T cell differentiation |
2. P | GO:0001811 | negative regulation of type I hypersensitivity |
2. P | GO:0043220 | Schmidt-Lanterman incisure |
2. P | GO:0090557 | establishment of endothelial intestinal barrier |
2. P | GO:0001805 | positive regulation of type III hypersensitivity |
2. P | GO:0051138 | positive regulation of NK T cell differentiation |
2. P | GO:0031225 | anchored component of membrane |
2. P | GO:0010983 | positive regulation of high-density lipoprotein particle clearance |
2. P | GO:0034116 | positive regulation of heterotypic cell-cell adhesion |
2. P | GO:0045088 | regulation of innate immune response |
2. P | GO:0001952 | regulation of cell-matrix adhesion |
2. P | GO:2000350 | positive regulation of CD40 signaling pathway |
2. P | GO:0005923 | bicellular tight junction |
2. P | GO:0005739 | mitochondrion |
2. P | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential |
2. P | GO:0030225 | macrophage differentiation |
2. P | GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion |
2. P | GO:0086010 | membrane depolarization during action potential |
2. P | GO:0043507 | positive regulation of JUN kinase activity |
2. P | GO:0001818 | negative regulation of cytokine production |
2. P | GO:1903829 | positive regulation of protein localization |
2. P | GO:0140052 | cellular response to oxidised low-density lipoprotein particle stimulus |
2. P | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway |
2. P | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly |
2. P | GO:2000774 | positive regulation of cellular senescence |
2. P | GO:0070821 | tertiary granule membrane |
2. P | GO:0044853 | plasma membrane raft |
2. P | GO:0046598 | positive regulation of viral entry into host cell |
2. P | GO:0002526 | acute inflammatory response |
2. P | GO:0007565 | female pregnancy |
2. P | GO:0034333 | adherens junction assembly |
2. P | GO:0001934 | positive regulation of protein phosphorylation |
2. P | GO:0086091 | regulation of heart rate by cardiac conduction |
2. P | GO:0032755 | positive regulation of interleukin-6 production |
2. P | GO:0042129 | regulation of T cell proliferation |
2. P | GO:0035020 | regulation of Rac protein signal transduction |
2. P | GO:0030315 | T-tubule |
2. P | GO:0023024 | MHC class I protein complex binding |
2. P | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway |
2. P | GO:0034186 | apolipoprotein A-I binding |
2. P | GO:0050859 | negative regulation of B cell receptor signaling pathway |
2. P | GO:0010575 | positive regulation of vascular endothelial growth factor production |
2. P | GO:0035397 | helper T cell enhancement of adaptive immune response |
2. P | GO:0031032 | actomyosin structure organization |
2. P | GO:1903670 | regulation of sprouting angiogenesis |
2. P | GO:0032733 | positive regulation of interleukin-10 production |
2. P | GO:1901731 | positive regulation of platelet aggregation |
2. P | GO:1904645 | response to amyloid-beta |
2. P | GO:1900027 | regulation of ruffle assembly |
2. P | GO:0097062 | dendritic spine maintenance |
2. P | GO:0007338 | single fertilization |
2. P | GO:0035633 | maintenance of blood-brain barrier |
2. P | GO:0090331 | negative regulation of platelet aggregation |
2. P | GO:0086002 | cardiac muscle cell action potential involved in contraction |
2. P | GO:2000249 | regulation of actin cytoskeleton reorganization |
2. P | GO:0007165 | signal transduction |
2. P | GO:0031774 | leukotriene receptor binding |
2. P | GO:2001171 | positive regulation of ATP biosynthetic process |
2. P | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway |
2. P | GO:0002668 | negative regulation of T cell anergy |
2. P | GO:1900453 | negative regulation of long-term synaptic depression |
2. P | GO:0046689 | response to mercury ion |
2. P | GO:0045590 | negative regulation of regulatory T cell differentiation |
2. P | GO:0043031 | negative regulation of macrophage activation |
2. P | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity |
2. P | GO:0015721 | bile acid and bile salt transport |
2. P | GO:0048006 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
2. P | GO:0090559 | regulation of membrane permeability |
2. P | GO:0030593 | neutrophil chemotaxis |
2. P | GO:0099059 | integral component of presynaptic active zone membrane |
2. P | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus |
2. P | GO:0010760 | negative regulation of macrophage chemotaxis |
2. P | GO:0046549 | retinal cone cell development |
2. P | GO:0030057 | desmosome |
2. P | GO:0030853 | negative regulation of granulocyte differentiation |
2. P | GO:0060101 | negative regulation of phagocytosis, engulfment |
2. P | GO:0051135 | positive regulation of NK T cell activation |
2. P | GO:0002270 | plasmacytoid dendritic cell activation |
2. P | GO:0045777 | positive regulation of blood pressure |
2. P | GO:0070348 | negative regulation of brown fat cell proliferation |
2. P | GO:0071219 | cellular response to molecule of bacterial origin |
2. P | GO:0001814 | negative regulation of antibody-dependent cellular cytotoxicity |
2. P | GO:0006968 | cellular defense response |
2. P | GO:0061041 | regulation of wound healing |
2. P | GO:0002397 | MHC class I protein complex assembly |
2. P | GO:0001518 | voltage-gated sodium channel complex |
2. P | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential |
2. P | GO:0007229 | integrin-mediated signaling pathway |
2. P | GO:0150003 | regulation of spontaneous synaptic transmission |
2. P | GO:1903082 | positive regulation of C-C chemokine receptor CCR7 signaling pathway |
2. P | GO:0045601 | regulation of endothelial cell differentiation |
2. P | GO:0019871 | sodium channel inhibitor activity |
2. P | GO:0110089 | regulation of hippocampal neuron apoptotic process |
2. P | GO:1902396 | protein localization to bicellular tight junction |
2. P | GO:0046330 | positive regulation of JNK cascade |
2. P | GO:0050728 | negative regulation of inflammatory response |
2. P | GO:1905150 | regulation of voltage-gated sodium channel activity |
2. P | GO:0002638 | negative regulation of immunoglobulin production |
2. P | GO:0120146 | sulfatide binding |
2. P | GO:1900745 | positive regulation of p38MAPK cascade |
2. P | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway |
2. P | GO:0150077 | regulation of neuroinflammatory response |
2. P | GO:0031103 | axon regeneration |
2. P | GO:0001914 | regulation of T cell mediated cytotoxicity |
2. P | GO:0032757 | positive regulation of interleukin-8 production |
2. P | GO:0019209 | kinase activator activity |
2. P | GO:0033674 | positive regulation of kinase activity |
2. P | GO:0098671 | adhesion receptor-mediated virion attachment to host cell |
2. P | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
2. P | GO:0071223 | cellular response to lipoteichoic acid |
2. P | GO:0002456 | T cell mediated immunity |
2. P | GO:0002726 | positive regulation of T cell cytokine production |
2. P | GO:1905286 | serine-type peptidase complex |
2. P | GO:2000353 | positive regulation of endothelial cell apoptotic process |
2. P | GO:0032703 | negative regulation of interleukin-2 production |
2. P | GO:1905898 | positive regulation of response to endoplasmic reticulum stress |
2. P | GO:0097028 | dendritic cell differentiation |
2. P | GO:0048534 | hematopoietic or lymphoid organ development |
2. P | GO:0001525 | angiogenesis |
2. P | GO:0071636 | positive regulation of transforming growth factor beta production |
2. P | GO:0043113 | receptor clustering |
2. P | GO:0034151 | regulation of toll-like receptor 6 signaling pathway |
2. P | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity |
2. P | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
2. P | GO:0002336 | B-1 B cell lineage commitment |
2. P | GO:0090027 | negative regulation of monocyte chemotaxis |
2. P | GO:0002622 | regulation of B cell antigen processing and presentation |
2. P | GO:0002695 | negative regulation of leukocyte activation |
2. P | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation |
2. P | GO:1904465 | negative regulation of matrix metallopeptidase secretion |
2. P | GO:0003407 | neural retina development |
2. P | GO:2000810 | regulation of bicellular tight junction assembly |
2. P | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation |
2. P | GO:0061337 | cardiac conduction |
2. P | GO:0004888 | transmembrane signaling receptor activity |
2. P | GO:0001820 | serotonin secretion |
2. P | GO:0099557 | trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission |
2. P | GO:0006948 | induction by virus of host cell-cell fusion |
2. P | GO:0017080 | sodium channel regulator activity |
2. P | GO:0060074 | synapse maturation |
2. P | GO:1901224 | positive regulation of NIK/NF-kappaB signaling |
2. P | GO:0045176 | apical protein localization |
3. B | GO:0010737 | protein kinase A signaling |
3. B | GO:0098797 | plasma membrane protein complex |
3. B | GO:0007414 | axonal defasciculation |
3. B | GO:0003094 | glomerular filtration |
3. B | GO:0030913 | paranodal junction assembly |
3. B | GO:0050709 | negative regulation of protein secretion |
3. B | GO:2001198 | regulation of dendritic cell differentiation |
3. B | GO:0007254 | JNK cascade |
3. B | GO:0008307 | structural constituent of muscle |
3. B | GO:0055037 | recycling endosome |
3. B | GO:0019815 | B cell receptor complex |
3. B | GO:0051371 | muscle alpha-actinin binding |
3. B | GO:0031430 | M band |
3. B | GO:0048668 | collateral sprouting |
3. B | GO:0019731 | antibacterial humoral response |
3. B | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
3. B | GO:0045580 | regulation of T cell differentiation |
3. B | GO:0006953 | acute-phase response |
3. B | GO:2000521 | negative regulation of immunological synapse formation |
3. B | GO:0043194 | axon initial segment |
3. B | GO:0030240 | skeletal muscle thin filament assembly |
3. B | GO:0042805 | actinin binding |
3. B | GO:0042609 | CD4 receptor binding |
3. B | GO:0050871 | positive regulation of B cell activation |
3. B | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste |
3. B | GO:0050808 | synapse organization |
3. B | GO:0097493 | structural molecule activity conferring elasticity |
3. B | GO:0033270 | paranode region of axon |
3. B | GO:0001895 | retina homeostasis |
3. B | GO:0055013 | cardiac muscle cell development |
3. B | GO:0007416 | synapse assembly |
3. B | GO:0005524 | ATP binding |
3. B | GO:0042571 | immunoglobulin complex, circulating |
3. B | GO:0017124 | SH3 domain binding |
3. B | GO:0032092 | positive regulation of protein binding |
3. B | GO:0097421 | liver regeneration |
3. B | GO:0030277 | maintenance of gastrointestinal epithelium |
3. B | GO:0002667 | regulation of T cell anergy |
3. B | GO:0071656 | negative regulation of granulocyte colony-stimulating factor production |
3. B | GO:0060419 | heart growth |
3. B | GO:0055003 | cardiac myofibril assembly |
3. B | GO:0002418 | immune response to tumor cell |
3. B | GO:0043323 | positive regulation of natural killer cell degranulation |
3. B | GO:2001222 | regulation of neuron migration |
3. B | GO:0005865 | striated muscle thin filament |
3. B | GO:0035418 | protein localization to synapse |
3. B | GO:2000568 | positive regulation of memory T cell activation |
3. B | GO:0032815 | negative regulation of natural killer cell activation |
3. B | GO:0071205 | protein localization to juxtaparanode region of axon |
3. B | GO:0034154 | toll-like receptor 7 signaling pathway |
3. B | GO:0072562 | blood microparticle |
3. B | GO:0043056 | forward locomotion |
3. B | GO:2001189 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
3. B | GO:0032154 | cleavage furrow |
3. B | GO:0099560 | synaptic membrane adhesion |
3. B | GO:0009826 | unidimensional cell growth |
3. B | GO:0003382 | epithelial cell morphogenesis |
3. B | GO:0016199 | axon midline choice point recognition |
3. B | GO:0045022 | early endosome to late endosome transport |
3. B | GO:0045859 | regulation of protein kinase activity |
3. B | GO:0098688 | parallel fiber to Purkinje cell synapse |
3. B | GO:0031674 | I band |
3. B | GO:0032655 | regulation of interleukin-12 production |
3. B | GO:0045162 | clustering of voltage-gated sodium channels |
3. B | GO:0070700 | BMP receptor binding |
3. B | GO:0055072 | iron ion homeostasis |
3. B | GO:0071751 | secretory IgA immunoglobulin complex |
3. B | GO:0002652 | regulation of tolerance induction dependent upon immune response |
3. B | GO:0044062 | regulation of excretion |
3. B | GO:0097454 | Schwann cell microvillus |
3. B | GO:0055008 | cardiac muscle tissue morphogenesis |
3. B | GO:0031324 | negative regulation of cellular metabolic process |
3. B | GO:0019814 | immunoglobulin complex |
3. B | GO:0032687 | negative regulation of interferon-alpha production |
3. B | GO:0002826 | negative regulation of T-helper 1 type immune response |
3. B | GO:0032712 | negative regulation of interleukin-3 production |
3. B | GO:1901897 | regulation of relaxation of cardiac muscle |
3. B | GO:0099056 | integral component of presynaptic membrane |
3. B | GO:0003300 | cardiac muscle hypertrophy |
3. B | GO:0031433 | telethonin binding |
3. B | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
3. B | GO:0070373 | negative regulation of ERK1 and ERK2 cascade |
3. B | GO:0009617 | response to bacterium |
3. B | GO:0099629 | postsynaptic specialization of symmetric synapse |
3. B | GO:0030537 | larval behavior |
3. B | GO:0048769 | sarcomerogenesis |
3. B | GO:0097708 | intracellular vesicle |
3. B | GO:0007422 | peripheral nervous system development |
3. B | GO:0002175 | protein localization to paranode region of axon |
3. B | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
3. B | GO:0048681 | negative regulation of axon regeneration |
3. B | GO:0071756 | pentameric IgM immunoglobulin complex |
3. B | GO:0048679 | regulation of axon regeneration |
3. B | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation |
3. B | GO:0071748 | monomeric IgA immunoglobulin complex |
3. B | GO:0002838 | negative regulation of immune response to tumor cell |
3. B | GO:0030241 | skeletal muscle myosin thick filament assembly |
3. B | GO:0008039 | synaptic target recognition |
3. B | GO:0046872 | metal ion binding |
3. B | GO:0030509 | BMP signaling pathway |
3. B | GO:0042552 | myelination |
3. B | GO:0035995 | detection of muscle stretch |
3. B | GO:0042742 | defense response to bacterium |
3. B | GO:0005918 | septate junction |
3. B | GO:0002666 | positive regulation of T cell tolerance induction |
3. B | GO:0050830 | defense response to Gram-positive bacterium |
3. B | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation |
3. B | GO:0061042 | vascular wound healing |
Homologs
1. PB indicates the homologs that are found by both PROST and BLAST.
2. P indicates homologs that are only found by PROST.
3. B indicates homologs that are only found by BLAST.
Source | Homolog | Description | FATCAT p-val | PROST Evalue | BLAST Evalue |
---|---|---|---|---|---|
1. PB | Q7ZXX1 | Cell adhesion molecule 3 | 1.56e-07 | 4.36e-08 | 1.80e-08 |
1. PB | O19477 | Major histocompatibility complex class I-related gene protein | 1.01e-02 | 8.84e-05 | 0.011 |
1. PB | P55899 | IgG receptor FcRn large subunit p51 | 1.71e-02 | 4.57e-07 | 0.010 |
1. PB | P06339 | H-2 class I histocompatibility antigen, D-37 alpha chain | 2.14e-02 | 5.84e-07 | 0.003 |
1. PB | O46631 | Tyrosine-protein phosphatase non-receptor type substrate 1 | 0.00e+00 | 8.12e-07 | 0.0 |
1. PB | P13762 | HLA class II histocompatibility antigen, DR beta 4 chain | 9.95e-03 | 1.94e-07 | 0.032 |
1. PB | P04223 | H-2 class I histocompatibility antigen, K-K alpha chain | 9.81e-03 | 1.33e-07 | 0.006 |
1. PB | P13750 | Patr class I histocompatibility antigen, B-1 alpha chain (Fragment) | 1.16e-02 | 1.84e-06 | 0.001 |
1. PB | P35737 | Class II histocompatibility antigen, M beta 1 chain | 9.71e-03 | 1.83e-08 | 1.21e-04 |
1. PB | P13752 | BOLA class I histocompatibility antigen, alpha chain BL3-6 | 8.37e-03 | 5.32e-09 | 0.002 |
1. PB | P06341 | Rano class II histocompatibility antigen, A beta chain (Fragment) | 4.47e-03 | 1.35e-03 | 0.008 |
1. PB | P04221 | Ig mu chain C region membrane-bound form | 3.06e-04 | 7.55e-04 | 8.07e-05 |
1. PB | P33617 | Mamu class I histocompatibility antigen, alpha chain F | 1.31e-03 | 1.19e-04 | 0.003 |
1. PB | Q6MG97 | Butyrophilin-like protein 2 | 4.73e-06 | 1.27e-02 | 3.45e-05 |
1. PB | P20040 | H-2 class II histocompatibility antigen, E-Q beta chain | 5.59e-03 | 2.45e-05 | 0.008 |
1. PB | P01889 | HLA class I histocompatibility antigen, B alpha chain | 3.32e-03 | 3.71e-07 | 0.003 |
1. PB | Q9GL43 | Hereditary hemochromatosis protein homolog | 2.17e-03 | 1.40e-04 | 5.90e-04 |
1. PB | Q1WIM3 | Cell adhesion molecule 3 | 2.60e-06 | 2.80e-09 | 9.51e-11 |
1. PB | P06345 | H-2 class II histocompatibility antigen, A-S beta chain | 7.43e-03 | 1.48e-05 | 0.028 |
1. PB | Q9BY67 | Cell adhesion molecule 1 | 3.18e-06 | 5.41e-06 | 1.28e-04 |
1. PB | Q90460 | CD166 antigen homolog A | 1.22e-04 | 4.40e-03 | 0.021 |
1. PB | P04439 | HLA class I histocompatibility antigen, A alpha chain | 2.24e-03 | 1.97e-07 | 0.002 |
1. PB | O35799 | Hereditary hemochromatosis protein homolog | 1.87e-02 | 2.65e-07 | 0.003 |
1. PB | P30385 | Class I histocompatibility antigen, Gogo-C*0201 alpha chain | 1.18e-02 | 2.34e-07 | 0.004 |
1. PB | P70387 | Hereditary hemochromatosis protein homolog | 2.76e-04 | 1.09e-06 | 0.002 |
1. PB | Q9GKZ0 | Hereditary hemochromatosis protein homolog | 1.22e-02 | 1.84e-04 | 6.74e-04 |
1. PB | Q95IT3 | Patr class I histocompatibility antigen, alpha chain E | 6.59e-03 | 1.70e-06 | 0.001 |
1. PB | Q8N3J6 | Cell adhesion molecule 2 | 3.77e-07 | 5.12e-04 | 2.74e-09 |
1. PB | P16212 | Popy class I histocompatibility antigen, alpha chain E (Fragment) | 1.34e-02 | 2.01e-08 | 0.015 |
1. PB | P30388 | Class I histocompatibility antigen, Gogo-OKO alpha chain | 6.42e-03 | 1.42e-06 | 4.50e-04 |
1. PB | P23088 | Ig heavy chain C region, membrane-bound form | 2.96e-05 | 2.71e-05 | 3.61e-04 |
1. PB | P30378 | Class I histocompatibility antigen, Gogo-A*0501 alpha chain | 4.41e-03 | 4.68e-07 | 0.027 |
1. PB | P01869 | Ig gamma-1 chain C region, membrane-bound form | 3.49e-06 | 1.20e-06 | 0.006 |
1. PB | P30386 | Class I histocompatibility antigen, Gogo-C*0202 alpha chain | 1.20e-02 | 2.17e-07 | 0.004 |
1. PB | Q91664 | V-set and immunoglobulin domain-containing protein 1 | 1.69e-04 | 3.43e-03 | 0.045 |
1. PB | P17693 | HLA class I histocompatibility antigen, alpha chain G | 1.45e-03 | 7.42e-03 | 0.022 |
1. PB | Q66KX2 | Cell adhesion molecule 4 | 1.32e-08 | 2.07e-10 | 2.59e-06 |
1. PB | P30382 | Class I histocompatibility antigen, Gogo-B*0201 alpha chain | 1.31e-03 | 4.74e-07 | 0.002 |
1. PB | P30381 | Class I histocompatibility antigen, Gogo-B*0103 alpha chain | 6.59e-04 | 4.57e-07 | 0.002 |
1. PB | P16210 | Patr class I histocompatibility antigen, A-5 alpha chain | 9.21e-04 | 3.44e-07 | 0.003 |
1. PB | P16209 | Patr class I histocompatibility antigen, A-2 alpha chain | 1.09e-03 | 5.77e-07 | 5.61e-04 |
1. PB | P97797 | Tyrosine-protein phosphatase non-receptor type substrate 1 | 0.00e+00 | 3.89e-07 | 5.67e-147 |
1. PB | Q1WIM2 | Cell adhesion molecule 2 | 3.12e-07 | 4.53e-03 | 2.00e-09 |
1. PB | P01867 | Ig gamma-2B chain C region | 7.85e-06 | 1.35e-02 | 0.002 |
1. PB | Q30201 | Hereditary hemochromatosis protein | 1.33e-03 | 1.10e-05 | 0.046 |
1. PB | Q29980 | MHC class I polypeptide-related sequence B | 8.07e-03 | 4.20e-05 | 1.81e-04 |
1. PB | Q7TSP5 | V-set domain containing T-cell activation inhibitor 1 | 1.36e-03 | 1.38e-05 | 2.92e-04 |
1. PB | P97710 | Tyrosine-protein phosphatase non-receptor type substrate 1 | 0.00e+00 | 3.44e-07 | 1.03e-144 |
1. PB | Q9GL41 | Hereditary hemochromatosis protein homolog | 2.22e-03 | 5.26e-05 | 8.07e-05 |
1. PB | Q8BLQ9 | Cell adhesion molecule 2 | 3.96e-08 | 9.29e-04 | 2.29e-09 |
1. PB | P15464 | SMH class II histocompatibility antigen, beta-1 chain | 1.78e-04 | 3.90e-06 | 0.007 |
1. PB | P03987 | Ig gamma-3 chain C region | 3.94e-05 | 6.12e-04 | 0.007 |
1. PB | P14432 | H-2 class I histocompatibility antigen, TLA(B) alpha chain | 9.93e-03 | 7.64e-07 | 3.16e-04 |
1. PB | P15979 | Class I histocompatibility antigen, F10 alpha chain | 1.45e-02 | 1.59e-05 | 0.003 |
1. PB | Q95IT1 | Patr class I histocompatibility antigen, alpha chain G | 6.28e-04 | 8.03e-04 | 0.020 |
1. PB | P18469 | H-2 class II histocompatibility antigen, I-E beta chain | 5.54e-03 | 5.93e-04 | 0.008 |
1. PB | P78324 | Tyrosine-protein phosphatase non-receptor type substrate 1 | 0.00e+00 | 1.94e-07 | 0.0 |
1. PB | P30380 | Class I histocompatibility antigen, Gogo-B*0102 alpha chain | 1.26e-03 | 5.36e-07 | 0.002 |
1. PB | P01897 | H-2 class I histocompatibility antigen, L-D alpha chain | 1.71e-03 | 1.81e-08 | 0.007 |
1. PB | Q5TFQ8 | Signal-regulatory protein beta-1 isoform 3 | 0 | 1.96e-145 | 0.0 |
1. PB | Q30154 | HLA class II histocompatibility antigen, DR beta 5 chain | 3.41e-03 | 1.92e-04 | 0.032 |
1. PB | P14427 | H-2 class I histocompatibility antigen, D-P alpha chain | 2.90e-03 | 1.53e-07 | 4.40e-04 |
1. PB | Q99N28 | Cell adhesion molecule 3 | 2.96e-07 | 5.19e-10 | 5.06e-11 |
1. PB | P11364 | Viral T-cell receptor beta chain-like T17T-22 | NA | 9.85e-17 | 0.009 |
1. PB | P30516 | Class I histocompatibility antigen, B alpha chain | 5.04e-03 | 1.03e-08 | 0.004 |
1. PB | P30377 | Class I histocompatibility antigen, Gogo-A*0401 alpha chain | 1.37e-03 | 4.31e-08 | 0.009 |
1. PB | P06340 | HLA class II histocompatibility antigen, DO alpha chain | 5.86e-03 | 8.12e-07 | 1.21e-04 |
1. PB | O75144 | ICOS ligand | 2.44e-05 | 6.17e-11 | 0.007 |
1. PB | P01901 | H-2 class I histocompatibility antigen, K-B alpha chain | 1.16e-02 | 8.02e-07 | 0.025 |
1. PB | P16215 | Patr class I histocompatibility antigen, CH28 alpha chain | 8.50e-04 | 2.71e-04 | 0.002 |
1. PB | P01894 | RLA class I histocompatibility antigen, alpha chain 11/11 | 6.90e-03 | 2.59e-09 | 5.61e-04 |
1. PB | P30515 | Saoe class I histocompatibility antigen, A alpha chain | 1.10e-03 | 9.53e-09 | 0.008 |
1. PB | P18468 | H-2 class II histocompatibility antigen, I-A beta chain | 8.00e-03 | 1.09e-04 | 0.006 |
1. PB | P18466 | DLA class I histocompatibility antigen, A9/A9 alpha chain | 1.86e-03 | 3.53e-07 | 1.19e-04 |
1. PB | P04231 | H-2 class II histocompatibility antigen, E-S beta chain (Fragment) | 2.51e-03 | 8.56e-05 | 0.010 |
1. PB | P16391 | RT1 class I histocompatibility antigen, AA alpha chain | 1.08e-02 | 2.11e-09 | 0.006 |
1. PB | O00241 | Signal-regulatory protein beta-1 | 0.00e+00 | 4.70e-94 | 0.0 |
1. PB | Q8SPV9 | IgG receptor FcRn large subunit p51 | 1.48e-02 | 1.62e-06 | 0.008 |
1. PB | Q8R5M8 | Cell adhesion molecule 1 | 5.28e-07 | 2.07e-04 | 1.72e-04 |
1. PB | P0DSE1 | M1-specific T cell receptor alpha chain | 3.98e-03 | 2.54e-11 | 0.030 |
1. PB | P16211 | Popy Class I histocompatibility antigen, A-1 alpha chain | 1.19e-02 | 6.68e-07 | 0.007 |
1. PB | Q9GL42 | Hereditary hemochromatosis protein homolog | 2.07e-03 | 7.41e-05 | 8.29e-05 |
1. PB | P18470 | DLA class II histocompatibility antigen, DR-1 beta chain | 7.47e-03 | 7.47e-04 | 0.006 |
1. PB | P01915 | H-2 class II histocompatibility antigen, E-D beta chain | 7.24e-03 | 5.08e-05 | 0.016 |
1. PB | P14483 | H-2 class II histocompatibility antigen, A beta chain | 1.06e-02 | 9.14e-05 | 0.026 |
1. PB | P28068 | HLA class II histocompatibility antigen, DM beta chain | 8.32e-03 | 2.17e-07 | 0.003 |
1. PB | P15982 | SLA class II histocompatibility antigen, DQ haplotype C beta chain | 1.81e-02 | 7.57e-03 | 1.21e-05 |
1. PB | P20756 | RLA class II histocompatibility antigen, DP beta chain | 7.56e-03 | 5.68e-05 | 0.013 |
1. PB | Q61559 | IgG receptor FcRn large subunit p51 | 1.15e-02 | 3.64e-08 | 1.33e-05 |
1. PB | P13749 | Patr class I histocompatibility antigen, A-126 alpha chain | 3.86e-03 | 1.15e-07 | 8.27e-04 |
1. PB | P01900 | H-2 class I histocompatibility antigen, D-D alpha chain | 3.88e-03 | 1.39e-09 | 0.003 |
1. PB | P30511 | HLA class I histocompatibility antigen, alpha chain F | 7.87e-04 | 1.01e-04 | 0.006 |
1. PB | Q9TVC8 | BoLa class II histocompatibility antigen, DQB*0101 beta chain | 2.16e-02 | 1.76e-03 | 0.032 |
1. PB | Q6AYP5 | Cell adhesion molecule 1 | 5.13e-06 | 5.32e-05 | 8.11e-05 |
1. PB | Q9P1W8 | Signal-regulatory protein gamma | 0.00e+00 | 1.29e-69 | 0.0 |
1. PB | Q5JXA9 | Signal-regulatory protein beta-2 | 6.26e-05 | 3.62e-09 | 2.31e-21 |
1. PB | P13751 | Patr class I histocompatibility antigen, B-2 alpha chain | 1.17e-03 | 2.09e-07 | 0.003 |
1. PB | P13599 | IgG receptor FcRn large subunit p51 | 5.92e-03 | 8.91e-08 | 2.11e-05 |
1. PB | Q9JI59 | Junctional adhesion molecule B | 1.52e-04 | 2.26e-07 | 0.008 |
1. PB | P06140 | RLA class I histocompatibility antigen, alpha chain 19-1 | 6.92e-03 | 1.80e-09 | 5.66e-04 |
1. PB | P60018 | Hereditary hemochromatosis protein homolog | 2.56e-02 | 1.10e-05 | 0.046 |
1. PB | Q8N126 | Cell adhesion molecule 3 | 6.41e-07 | 6.92e-10 | 1.43e-09 |
1. PB | P30379 | Class I histocompatibility antigen, Gogo-B*0101 alpha chain | 2.51e-03 | 7.37e-07 | 0.002 |
1. PB | P04440 | HLA class II histocompatibility antigen, DP beta 1 chain | 5.64e-03 | 2.53e-05 | 1.79e-04 |
1. PB | P06342 | H-2 class II histocompatibility antigen, A-Q beta chain | 9.97e-03 | 1.03e-04 | 0.009 |
1. PB | P06346 | H-2 class II histocompatibility antigen, A-F beta chain (Fragment) | 5.89e-03 | 3.85e-07 | 0.009 |
1. PB | Q5RD09 | Major histocompatibility complex class I-related gene protein | 1.03e-03 | 1.61e-04 | 0.022 |
1. PB | P10321 | HLA class I histocompatibility antigen, C alpha chain | 1.88e-03 | 9.78e-09 | 0.016 |
1. PB | P03991 | H-2 class I histocompatibility antigen, K-W28 alpha chain | 1.30e-02 | 2.67e-06 | 0.013 |
1. PB | P01899 | H-2 class I histocompatibility antigen, D-B alpha chain | 5.64e-03 | 1.31e-08 | 0.010 |
1. PB | P30517 | Saoe class I histocompatibility antigen, C alpha chain | 2.75e-03 | 2.72e-07 | 0.005 |
1. PB | P79483 | HLA class II histocompatibility antigen, DR beta 3 chain | 6.99e-03 | 4.82e-06 | 0.026 |
1. PB | P30387 | Class I histocompatibility antigen, Gogo-C*0203 alpha chain | 2.44e-03 | 3.69e-08 | 0.004 |
1. PB | P06343 | H-2 class II histocompatibility antigen, A-K beta chain | 5.28e-03 | 3.68e-05 | 0.022 |
1. PB | P0DTU4 | T cell receptor beta chain MC.7.G5 | 3.00e-05 | 4.65e-14 | 0.006 |
1. PB | P05538 | HLA class II histocompatibility antigen, DQ beta 2 chain | 3.16e-03 | 2.00e-05 | 0.001 |
1. PB | P33681 | T-lymphocyte activation antigen CD80 | 2.40e-05 | 1.00e-17 | 0.017 |
1. PB | Q8HWB0 | Major histocompatibility complex class I-related gene protein | 4.33e-04 | 8.29e-04 | 6.29e-06 |
1. PB | P01921 | H-2 class II histocompatibility antigen, A-D beta chain | 8.16e-03 | 8.46e-05 | 0.008 |
1. PB | P30686 | Patr class I histocompatibility antigen, C alpha chain | 2.02e-03 | 9.78e-09 | 0.031 |
1. PB | Q7Z7D3 | V-set domain-containing T-cell activation inhibitor 1 | 6.08e-04 | 5.81e-04 | 0.003 |
1. PB | Q2KN22 | IgG receptor FcRn large subunit p51 | 5.03e-03 | 5.94e-05 | 0.009 |
1. PB | Q501W4 | V-set domain-containing T-cell activation inhibitor 1 | 1.48e-03 | 8.73e-06 | 7.40e-04 |
1. PB | P13747 | HLA class I histocompatibility antigen, alpha chain E | 6.60e-03 | 6.44e-07 | 7.01e-04 |
1. PB | P01865 | Ig gamma-2A chain C region, membrane-bound form | 1.86e-06 | 1.53e-02 | 0.005 |
1. PB | P30383 | Class I histocompatibility antigen, Gogo-C*0101/C*0102 alpha chain | 9.97e-04 | 7.00e-08 | 0.047 |
1. PB | Q6DJ83 | Cell adhesion molecule 2 | 6.76e-08 | 1.66e-05 | 7.80e-09 |
1. PB | P04230 | H-2 class II histocompatibility antigen, E-B beta chain | 7.31e-03 | 1.66e-05 | 0.008 |
1. PB | P06344 | H-2 class II histocompatibility antigen, A-U beta chain | 8.79e-03 | 1.63e-04 | 0.008 |
1. PB | P15980 | SLA class II histocompatibility antigen, DQ haplotype C alpha chain | 1.31e-02 | 8.46e-09 | 0.010 |
1. PB | Q00609 | T-lymphocyte activation antigen CD80 | 1.36e-04 | 2.32e-13 | 0.002 |
1. PB | Q29983 | MHC class I polypeptide-related sequence A | 5.34e-02 | 4.87e-06 | 4.82e-04 |
1. PB | P01893 | Putative HLA class I histocompatibility antigen, alpha chain H | 2.19e-03 | 1.61e-07 | 0.001 |
1. PB | P18211 | Rano class II histocompatibility antigen, D-1 beta chain | 3.86e-03 | 4.18e-06 | 0.006 |
1. PB | P13748 | Patr class I histocompatibility antigen, A-108 alpha chain | 1.07e-03 | 1.47e-06 | 0.001 |
2. P | A6NJW9 | T-cell surface glycoprotein CD8 beta-2 chain | 6.90e-03 | 1.46e-04 | NA |
2. P | P27930 | Interleukin-1 receptor type 2 | 1.71e-04 | 2.34e-07 | NA |
2. P | P50895 | Basal cell adhesion molecule | 4.50e-04 | 5.86e-03 | NA |
2. P | P03228 | Secreted protein BARF1 | NA | 9.98e-07 | NA |
2. P | Q6UDI7 | Envelope glycoprotein C | NA | 1.91e-06 | NA |
2. P | P40199 | Carcinoembryonic antigen-related cell adhesion molecule 6 | 1.69e-04 | 1.70e-11 | NA |
2. P | Q9NZQ7 | Programmed cell death 1 ligand 1 | 3.83e-04 | 1.07e-08 | NA |
2. P | P06126 | T-cell surface glycoprotein CD1a | 1.14e-02 | 9.94e-03 | NA |
2. P | Q58DA5 | Neurotrimin | 7.18e-05 | 7.03e-09 | NA |
2. P | P41725 | Brevican core protein (Fragment) | NA | 2.59e-02 | NA |
2. P | Q969P0 | Immunoglobulin superfamily member 8 | 5.23e-03 | 8.22e-07 | NA |
2. P | P20489 | High affinity immunoglobulin epsilon receptor subunit alpha | 3.60e-03 | 4.01e-04 | NA |
2. P | Q5R4D0 | Membrane cofactor protein | 9.96e-02 | 1.91e-05 | NA |
2. P | Q5NKU6 | Intercellular adhesion molecule 3 | 2.47e-03 | 1.22e-02 | NA |
2. P | Q9QJ17 | Putative OX-2 membrane glycoprotein homolog | NA | 6.01e-08 | NA |
2. P | Q9D7L8 | Transmembrane and immunoglobulin domain-containing protein 1 | 1.97e-04 | 5.14e-05 | NA |
2. P | A8MVZ5 | Butyrophilin-like protein 10 | 6.65e-04 | 1.15e-10 | NA |
2. P | Q68FQ2 | Junctional adhesion molecule C | 6.67e-05 | 6.48e-08 | NA |
2. P | Q9XSI1 | Cytotoxic T-lymphocyte protein 4 | 1.37e-03 | 1.14e-02 | NA |
2. P | Q9JHJ8 | ICOS ligand | 2.98e-04 | 1.76e-13 | NA |
2. P | P01882 | Ig delta chain C region membrane-bound form | 1.76e-05 | 9.25e-06 | NA |
2. P | Q9D3G2 | SLAM family member 8 | 4.53e-03 | 3.87e-09 | NA |
2. P | Q99795 | Cell surface A33 antigen | 4.27e-05 | 3.36e-03 | NA |
2. P | Q9Z0M9 | Interleukin-18-binding protein | 2.33e-02 | 1.03e-04 | NA |
2. P | P43632 | Killer cell immunoglobulin-like receptor 2DS4 | 3.22e-03 | 1.90e-04 | NA |
2. P | P78410 | Butyrophilin subfamily 3 member A2 | 1.63e-04 | 2.65e-05 | NA |
2. P | Q5NKT8 | Intercellular adhesion molecule 4 (Fragment) | 5.08e-05 | 9.51e-14 | NA |
2. P | P42072 | Cytotoxic T-lymphocyte protein 4 | 4.76e-03 | 2.85e-04 | NA |
2. P | F5HFB4 | Membrane glycoprotein UL18 | NA | 6.24e-08 | NA |
2. P | Q9D871 | Carcinoembryonic antigen-related cell adhesion molecule 18 | 6.47e-05 | 1.04e-17 | NA |
2. P | Q89738 | Putative OX-2 membrane glycoprotein homolog | NA | 5.04e-07 | NA |
2. P | Q9ES58 | Cell surface glycoprotein CD200 receptor 1 | 1.04e-03 | 5.76e-12 | NA |
2. P | Q9NY72 | Sodium channel subunit beta-3 | 3.19e-02 | 1.86e-02 | NA |
2. P | Q61790 | Lymphocyte activation gene 3 protein | 3.62e-03 | 7.33e-05 | NA |
2. P | Q5NKV2 | Intercellular adhesion molecule 2 | 8.94e-04 | 5.28e-04 | NA |
2. P | P12319 | High affinity immunoglobulin epsilon receptor subunit alpha | 1.80e-03 | 3.89e-08 | NA |
2. P | Q5NKV4 | Intercellular adhesion molecule 1 | 6.72e-05 | 5.67e-06 | NA |
2. P | Q5MGS7 | Beta-2-microglobulin | 4.30e-04 | 2.79e-02 | NA |
2. P | Q9QZZ2 | T-cell surface glycoprotein CD1b1 | 7.61e-03 | 3.18e-02 | NA |
2. P | Q9NP99 | Triggering receptor expressed on myeloid cells 1 | 4.57e-03 | 3.28e-07 | NA |
2. P | Q6UXN2 | Trem-like transcript 4 protein | 1.40e-02 | 3.63e-02 | NA |
2. P | Q09TM4 | Low affinity immunoglobulin gamma Fc region receptor III | 1.85e-02 | 3.71e-07 | NA |
2. P | Q9Z109 | V-set and immunoglobulin domain-containing protein 2 | 1.34e-04 | 4.82e-06 | NA |
2. P | Q5RDA5 | Triggering receptor expressed on myeloid cells 1 | 4.30e-03 | 1.74e-04 | NA |
2. P | P31997 | Carcinoembryonic antigen-related cell adhesion molecule 8 | 8.79e-05 | 1.31e-12 | NA |
2. P | Q90773 | Protein CEPU-1 | 9.30e-08 | 8.32e-07 | NA |
2. P | Q8VBT3 | Osteoclast-associated immunoglobulin-like receptor | 1.91e-02 | 1.49e-11 | NA |
2. P | P43303 | Interleukin-1 receptor type 2 | 1.47e-04 | 1.15e-10 | NA |
2. P | Q925P2 | Carcinoembryonic antigen-related cell adhesion molecule 2 | 6.41e-04 | 8.14e-09 | NA |
2. P | P04218 | OX-2 membrane glycoprotein | 5.52e-04 | 1.47e-15 | NA |
2. P | Q99PJ0 | Neurotrimin | 2.09e-05 | 2.31e-07 | NA |
2. P | Q13449 | Limbic system-associated membrane protein | 7.52e-06 | 1.12e-07 | NA |
2. P | Q15109 | Advanced glycosylation end product-specific receptor | 1.05e-04 | 1.71e-07 | NA |
2. P | Q00238 | Intercellular adhesion molecule 1 | 7.34e-05 | 4.54e-06 | NA |
2. P | Q8HWE5 | MHC class I-like protein MILL2 | 1.82e-02 | 1.16e-02 | NA |
2. P | P26151 | High affinity immunoglobulin gamma Fc receptor I | 2.14e-03 | 3.43e-02 | NA |
2. P | P09326 | CD48 antigen | 7.56e-04 | 2.16e-10 | NA |
2. P | Q8IYS5 | Osteoclast-associated immunoglobulin-like receptor | 6.01e-04 | 7.42e-03 | NA |
2. P | P23150 | H-2 class II histocompatibility antigen, I-E alpha chain (Fragment) | 2.33e-03 | 1.27e-10 | NA |
2. P | A0A140LHF2 | V-set and immunoglobulin domain-containing protein 10-like 2 | 2.44e-03 | 3.63e-02 | NA |
2. P | P35613 | Basigin | 6.45e-04 | 1.66e-10 | NA |
2. P | P29826 | Rano class II histocompatibility antigen, B-1 beta chain | 1.44e-02 | 6.53e-06 | NA |
2. P | Q09TM2 | Low affinity immunoglobulin gamma Fc region receptor III | 2.56e-02 | 3.71e-07 | NA |
2. P | Q28173 | Advanced glycosylation end product-specific receptor | 2.51e-05 | 7.09e-05 | NA |
2. P | P24358 | 36 kDa major membrane protein F5 | NA | 8.55e-04 | NA |
2. P | P16756 | Uncharacterized protein UL14 | NA | 5.42e-03 | NA |
2. P | Q4ACW4 | Antigen-presenting glycoprotein CD1d | 3.08e-02 | 3.04e-02 | NA |
2. P | O88775 | Embigin | 6.87e-03 | 4.02e-02 | NA |
2. P | O76036 | Natural cytotoxicity triggering receptor 1 | 5.83e-04 | 2.62e-04 | NA |
2. P | Q9NZC2 | Triggering receptor expressed on myeloid cells 2 | 3.39e-02 | 1.21e-02 | NA |
2. P | P14439 | H-2 class II histocompatibility antigen, E-U alpha chain | 1.17e-03 | 1.01e-05 | NA |
2. P | Q9GKM2 | Beta-2-microglobulin | 1.18e-04 | 1.13e-03 | NA |
2. P | Q22125 | Zwei Ig domain protein zig-6 | 9.09e-03 | 6.47e-03 | NA |
2. P | Q6UX52 | Protein IL-40 | 1.34e-02 | 8.10e-05 | NA |
2. P | P18181 | CD48 antigen | 7.01e-03 | 9.86e-08 | NA |
2. P | Q4PPC4 | Sodium channel subunit beta-1 | 6.06e-02 | 6.59e-04 | NA |
2. P | Q14773 | Intercellular adhesion molecule 4 | 1.33e-04 | 7.49e-13 | NA |
2. P | P09793 | Cytotoxic T-lymphocyte protein 4 | 6.21e-03 | 2.04e-02 | NA |
2. P | M0RAS4 | Immunoglobulin superfamily member 21 | 1.74e-04 | 1.69e-02 | NA |
2. P | Q8IYV9 | Izumo sperm-egg fusion protein 1 | 1.16e-01 | 8.59e-03 | NA |
2. P | P16573 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 3.00e-04 | 4.81e-04 | NA |
2. P | Q6XJV4 | Cell surface glycoprotein CD200 receptor 4 | 5.04e-04 | 3.51e-14 | NA |
2. P | Q9ES57 | Cell surface glycoprotein CD200 receptor 1 | 6.23e-03 | 2.55e-15 | NA |
2. P | A0A0G2K7V7 | MHC class I-like protein MILL2 | 6.98e-03 | 3.71e-03 | NA |
2. P | P15813 | Antigen-presenting glycoprotein CD1d | 1.04e-03 | 3.91e-02 | NA |
2. P | Q13046 | Putative pregnancy-specific beta-1-glycoprotein 7 | 2.82e-03 | 3.46e-02 | NA |
2. P | Q15238 | Pregnancy-specific beta-1-glycoprotein 5 | 4.86e-05 | 2.18e-06 | NA |
2. P | P01911 | HLA class II histocompatibility antigen, DRB1 beta chain | 4.81e-03 | 1.13e-06 | NA |
2. P | Q5NKV1 | Intercellular adhesion molecule 2 | 2.48e-04 | 9.38e-03 | NA |
2. P | Q17QN4 | Sodium channel subunit beta-1 | 7.93e-03 | 6.66e-04 | NA |
2. P | P20755 | RLA class II histocompatibility antigen, DP alpha-1 chain (Fragment) | 3.87e-03 | 1.79e-02 | NA |
2. P | P15151 | Poliovirus receptor | 4.12e-07 | 2.65e-14 | NA |
2. P | P42082 | T-lymphocyte activation antigen CD86 | 2.72e-04 | 8.81e-09 | NA |
2. P | P13597 | Intercellular adhesion molecule 1 | 1.15e-04 | 1.47e-06 | NA |
2. P | P16004 | T-cell surface glycoprotein CD4 | 6.58e-04 | 3.97e-04 | NA |
2. P | Q3KPI0 | Carcinoembryonic antigen-related cell adhesion molecule 21 | 1.62e-03 | 5.27e-14 | NA |
2. P | A0A0R4IGV4 | Junctional adhesion molecule 2A | 1.07e-04 | 1.91e-02 | NA |
2. P | Q5RAL8 | OX-2 membrane glycoprotein | 1.09e-05 | 8.61e-18 | NA |
2. P | P79184 | T-cell surface glycoprotein CD4 | 5.18e-04 | 1.52e-03 | NA |
2. P | Q90304 | CD166 antigen homolog | 3.91e-05 | 3.93e-04 | NA |
2. P | Q95460 | Major histocompatibility complex class I-related gene protein | 1.28e-02 | 1.51e-04 | NA |
2. P | P0DTU3 | T cell receptor alpha chain MC.7.G5 | 9.01e-04 | 3.25e-13 | NA |
2. P | P01830 | Thy-1 membrane glycoprotein | 1.23e-03 | 2.92e-03 | NA |
2. P | Q9HCN6 | Platelet glycoprotein VI | 1.55e-03 | 3.94e-03 | NA |
2. P | P01831 | Thy-1 membrane glycoprotein | 1.04e-02 | 6.73e-03 | NA |
2. P | Q9JK00 | Sodium channel subunit beta-3 | 1.55e-02 | 2.31e-02 | NA |
2. P | P05362 | Intercellular adhesion molecule 1 | 6.45e-05 | 3.55e-05 | NA |
2. P | P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A | 1.37e-02 | 8.02e-07 | NA |
2. P | Q63495 | Advanced glycosylation end product-specific receptor | 3.20e-05 | 8.63e-07 | NA |
2. P | P13598 | Intercellular adhesion molecule 2 | 1.16e-04 | 2.16e-03 | NA |
2. P | P01910 | H-2 class II histocompatibility antigen, A-K alpha chain | 6.42e-03 | 7.92e-09 | NA |
2. P | Q1WIM1 | Cell adhesion molecule 4 | 9.57e-08 | 4.20e-11 | NA |
2. P | O75015 | Low affinity immunoglobulin gamma Fc region receptor III-B | 1.72e-02 | 5.35e-11 | NA |
2. P | Q60513 | Low affinity immunoglobulin gamma Fc region receptor II | 6.96e-03 | 2.64e-02 | NA |
2. P | P41217 | OX-2 membrane glycoprotein | 2.27e-06 | 4.48e-17 | NA |
2. P | Q9Y639 | Neuroplastin | 1.86e-03 | 4.16e-10 | NA |
2. P | P19256 | Lymphocyte function-associated antigen 3 | 4.68e-03 | 8.86e-10 | NA |
2. P | P13765 | HLA class II histocompatibility antigen, DO beta chain | 8.83e-03 | 2.92e-04 | NA |
2. P | P27931 | Interleukin-1 receptor type 2 | 1.58e-04 | 4.85e-09 | NA |
2. P | P42070 | T-lymphocyte activation antigen CD80 | 5.53e-05 | 2.50e-16 | NA |
2. P | P21975 | Putative Ig-like V-type domain-containing protein FPV055 | NA | 1.38e-03 | NA |
2. P | Q00889 | Pregnancy-specific beta-1-glycoprotein 6 | 2.00e-03 | 1.26e-04 | NA |
2. P | P57087 | Junctional adhesion molecule B | 1.21e-03 | 2.80e-06 | NA |
2. P | Q64735 | Complement component receptor 1-like protein | 1.67e-01 | 1.54e-03 | NA |
2. P | Q28942 | Low affinity immunoglobulin gamma Fc region receptor III | 5.79e-03 | 7.51e-06 | NA |
2. P | P33729 | Intercellular adhesion molecule 1 (Fragment) | 2.21e-05 | 4.27e-03 | NA |
2. P | Q8TD46 | Cell surface glycoprotein CD200 receptor 1 | 1.76e-03 | 1.54e-12 | NA |
2. P | P30931 | Tissue factor | 2.43e-02 | 1.74e-03 | NA |
2. P | Q6QUN5 | Triggering receptor expressed on myeloid cells 1 | 1.47e-02 | 1.93e-05 | NA |
2. P | Q8N743 | Killer cell immunoglobulin-like receptor 3DL3 | 1.11e-03 | 1.70e-04 | NA |
2. P | Q5XI43 | Matrix remodeling-associated protein 8 | 7.92e-03 | 1.87e-03 | NA |
2. P | Q8HXJ7 | Sodium channel subunit beta-3 | 3.86e-02 | 1.77e-02 | NA |
2. P | P68325 | Envelope glycoprotein C | NA | 2.62e-13 | NA |
2. P | Q9H7L2 | Putative killer cell immunoglobulin-like receptor-like protein KIR3DX1 | 2.13e-04 | 9.59e-04 | NA |
2. P | P80943 | T-cell surface glycoprotein CD1b-3 (Fragment) | 4.57e-04 | 3.64e-03 | NA |
2. P | Q9BCU3 | Major histocompatibility complex class I-related gene protein | 7.51e-03 | 6.94e-05 | NA |
2. P | P20138 | Myeloid cell surface antigen CD33 | 1.30e-03 | 1.78e-03 | NA |
2. P | Q8SPV8 | Low affinity immunoglobulin gamma Fc region receptor II-a | 1.43e-02 | 3.18e-02 | NA |
2. P | P30376 | Class I histocompatibility antigen, Gogo-A*0201 alpha chain | 6.91e-04 | 9.98e-08 | NA |
2. P | P18467 | Patr class II histocompatibility antigen, DO beta chain | 3.65e-03 | 1.32e-03 | NA |
2. P | O75019 | Leukocyte immunoglobulin-like receptor subfamily A member 1 | 6.70e-04 | 3.55e-08 | NA |
2. P | H0VDZ8 | Low affinity immunoglobulin gamma Fc region receptor IV | 7.50e-04 | 5.92e-09 | NA |
2. P | Q8VHK6 | Interleukin-13 receptor subunit alpha-2 | 1.71e-03 | 4.31e-03 | NA |
2. P | Q6UXZ0 | Transmembrane and immunoglobulin domain-containing protein 1 | 1.65e-04 | 4.09e-06 | NA |
2. P | Q07984 | Translocon-associated protein subunit delta | 2.58e-02 | 1.56e-02 | NA |
2. P | P31809 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 5.37e-04 | 4.63e-07 | NA |
2. P | P0CW72 | Secreted protein BARF1 | NA | 9.98e-07 | NA |
2. P | A7XV04 | Selection and upkeep of intraepithelial T-cells protein 7 | 1.82e-04 | 1.19e-02 | NA |
2. P | P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b | 1.68e-03 | 5.02e-08 | NA |
2. P | P21611 | Beta-2-microglobulin | 2.13e-04 | 4.53e-02 | NA |
2. P | P06475 | Envelope glycoprotein C | NA | 5.51e-12 | NA |
2. P | Q7TPB4 | CD276 antigen | 1.27e-04 | 1.60e-11 | NA |
2. P | A3KPA0 | Junctional adhesion molecule 3B | 3.37e-05 | 5.77e-07 | NA |
2. P | Q6GMZ9 | V-set and immunoglobulin domain-containing protein 10 | 1.14e-05 | 3.53e-03 | NA |
2. P | P28067 | HLA class II histocompatibility antigen, DM alpha chain | 2.00e-03 | 6.06e-04 | NA |
2. P | P53788 | Sodium channel subunit beta-1 | 7.03e-02 | 1.72e-03 | NA |
2. P | Q61450 | Mast cell surface glycoprotein Gp49A | 1.05e-02 | 7.64e-07 | NA |
2. P | Q9JKE2 | Triggering receptor expressed on myeloid cells 1 | 9.74e-04 | 1.19e-07 | NA |
2. P | P12318 | Low affinity immunoglobulin gamma Fc region receptor II-a | 2.90e-03 | 2.35e-02 | NA |
2. P | Q9CX63 | Protein IL-40 | 3.69e-03 | 1.47e-06 | NA |
2. P | P23505 | Cell surface glycoprotein gp42 | 3.36e-04 | 1.57e-08 | NA |
2. P | P11610 | Antigen-presenting glycoprotein CD1d2 | 3.33e-03 | 4.02e-02 | NA |
2. P | Q5BK54 | Lymphocyte activation gene 3 protein | 1.07e-02 | 3.97e-04 | NA |
2. P | Q08338 | T-cell surface glycoprotein CD4 | 1.54e-04 | 5.86e-03 | NA |
2. P | P01730 | T-cell surface glycoprotein CD4 | 6.84e-04 | 2.14e-05 | NA |
2. P | Q9JLU8 | Tissue factor | 9.72e-03 | 4.37e-02 | NA |
2. P | Q864T8 | Beta-2-microglobulin | 2.17e-04 | 7.64e-03 | NA |
2. P | P08508 | Low affinity immunoglobulin gamma Fc region receptor III | 3.44e-02 | 1.15e-11 | NA |
2. P | P97546 | Neuroplastin | 2.65e-03 | 4.65e-08 | NA |
2. P | P18572 | Basigin | 3.69e-03 | 7.42e-11 | NA |
2. P | Q9MZ08 | Basal cell adhesion molecule | 4.70e-04 | 1.14e-03 | NA |
2. P | P20036 | HLA class II histocompatibility antigen, DP alpha 1 chain | 3.94e-03 | 5.30e-07 | NA |
2. P | Q9UM44 | HERV-H LTR-associating protein 2 | 1.76e-04 | 2.09e-05 | NA |
2. P | Q00320 | 36 kDa major membrane protein F5 | NA | 1.31e-03 | NA |
2. P | A8MTB9 | Carcinoembryonic antigen-related cell adhesion molecule 18 | 9.09e-05 | 9.55e-05 | NA |
2. P | Q8VCH2 | CMRF35-like molecule 5 | 3.53e-03 | 5.15e-03 | NA |
2. P | Q9UIR0 | Butyrophilin-like protein 2 | 9.01e-07 | 1.82e-02 | NA |
2. P | Q28806 | Intercellular adhesion molecule 1 | 6.17e-05 | 1.49e-06 | NA |
2. P | Q28740 | Basigin | 1.34e-02 | 6.52e-04 | NA |
2. P | Q9WUL5 | Programmed cell death 1 ligand 2 | 3.17e-04 | 1.02e-20 | NA |
2. P | P13753 | BOLA class I histocompatibility antigen, alpha chain BL3-7 | 6.58e-03 | 1.18e-07 | NA |
2. P | P04228 | H-2 class II histocompatibility antigen, A-D alpha chain | 2.31e-03 | 4.20e-08 | NA |
2. P | Q3B8P2 | Fc receptor-like A | 3.08e-03 | 1.71e-03 | NA |
2. P | P07725 | T-cell surface glycoprotein CD8 alpha chain | 3.01e-02 | 1.06e-02 | NA |
2. P | O18906 | CD226 antigen | 1.61e-03 | 1.46e-02 | NA |
2. P | Q26474 | Lachesin | 1.99e-08 | 1.25e-07 | NA |
2. P | Q9P121 | Neurotrimin | 5.92e-05 | 8.05e-08 | NA |
2. P | O88174 | Membrane cofactor protein | 8.47e-02 | 6.07e-05 | NA |
2. P | Q7Z3B1 | Neuronal growth regulator 1 | 1.57e-05 | 3.47e-10 | NA |
2. P | P11834 | Opioid-binding protein/cell adhesion molecule | 4.65e-05 | 2.44e-08 | NA |
2. P | A6NMB1 | Sialic acid-binding Ig-like lectin 16 | 6.08e-04 | 4.70e-06 | NA |
2. P | Q14943 | Killer cell immunoglobulin-like receptor 3DS1 | 1.22e-04 | 2.39e-05 | NA |
2. P | Q9D8B7 | Junctional adhesion molecule C | 7.42e-05 | 7.28e-07 | NA |
2. P | A6NGN9 | IgLON family member 5 | 1.05e-05 | 1.76e-08 | NA |
2. P | B6A8R8 | T-cell-interacting, activating receptor on myeloid cells protein 1 | 3.71e-04 | 4.19e-09 | NA |
2. P | P10252 | CD48 antigen | 3.54e-03 | 8.97e-13 | NA |
2. P | Q29612 | Interleukin-1 receptor type 2 | 1.63e-04 | 2.26e-08 | NA |
2. P | Q8NFZ8 | Cell adhesion molecule 4 | 1.40e-09 | 1.85e-11 | NA |
2. P | O02839 | Membrane cofactor protein | 7.01e-02 | 1.37e-05 | NA |
2. P | Q8VE98 | CD276 antigen | 1.10e-04 | 1.70e-11 | NA |
2. P | Q9BX67 | Junctional adhesion molecule C | 6.09e-05 | 6.76e-06 | NA |
2. P | Q8HWE7 | MHC class I-like protein MILL1 | 1.73e-02 | 6.73e-03 | NA |
2. P | P0DSE2 | M1-specific T cell receptor beta chain | 9.27e-05 | 1.61e-19 | NA |
2. P | Q0V881 | Lymphocyte antigen 6 complex locus protein G6f | 1.41e-03 | 2.07e-07 | NA |
2. P | Q3LRV9 | Trem-like transcript 4 protein | 8.60e-03 | 2.25e-02 | NA |
2. P | Q8R464 | Cell adhesion molecule 4 | 6.66e-08 | 9.31e-11 | NA |
2. P | Q9W6V2 | Neuronal growth regulator 1 | 5.26e-06 | 4.28e-06 | NA |
2. P | P0C191 | Platelet glycoprotein VI | 1.41e-03 | 9.99e-04 | NA |
2. P | P16410 | Cytotoxic T-lymphocyte protein 4 | 1.66e-03 | 4.27e-03 | NA |
2. P | P14436 | H-2 class II histocompatibility antigen, A-R alpha chain | 2.78e-03 | 7.13e-03 | NA |
2. P | A5A6L6 | Sodium channel subunit beta-1 | 6.13e-02 | 6.28e-03 | NA |
2. P | Q16557 | Pregnancy-specific beta-1-glycoprotein 3 | 4.29e-03 | 6.93e-03 | NA |
2. P | Q863H2 | Natural cytotoxicity triggering receptor 1 | 5.04e-03 | 3.44e-07 | NA |
2. P | P01903 | HLA class II histocompatibility antigen, DR alpha chain | 7.23e-04 | 9.25e-08 | NA |
2. P | G5EGI7 | Zwei Ig domain protein zig-1 | 3.91e-03 | 2.82e-07 | NA |
2. P | P04224 | H-2 class II histocompatibility antigen, E-K alpha chain | 1.18e-03 | 1.35e-05 | NA |
2. P | Q62186 | Translocon-associated protein subunit delta | 3.35e-02 | 9.47e-03 | NA |
2. P | P14378 | Envelope glycoprotein C homolog | NA | 1.65e-07 | NA |
2. P | Q6PCB8 | Embigin | 2.26e-03 | 1.42e-02 | NA |
2. P | P97952 | Sodium channel subunit beta-1 | 6.05e-02 | 4.96e-04 | NA |
2. P | Q9XSM7 | T-cell surface glycoprotein CD8 beta chain | 8.05e-02 | 9.98e-05 | NA |
2. P | P33500 | Envelope glycoprotein C homolog | NA | 1.36e-04 | NA |
2. P | P23735 | Ig mu chain C region membrane-bound form | 2.61e-05 | 9.16e-09 | NA |
2. P | P30375 | Class I histocompatibility antigen, Gogo-A*0101 alpha chain | 1.17e-03 | 4.31e-08 | NA |
2. P | P32506 | Poliovirus receptor homolog | 7.94e-07 | 6.18e-16 | NA |
2. P | Q28110 | Low affinity immunoglobulin gamma Fc region receptor II | 2.99e-02 | 4.19e-09 | NA |
2. P | P05540 | T-cell surface glycoprotein CD4 | 3.45e-04 | 9.69e-04 | NA |
2. P | P16003 | T-cell surface glycoprotein CD4 | 5.58e-04 | 9.01e-04 | NA |
2. P | Q08340 | T-cell surface glycoprotein CD4 | 4.55e-04 | 7.42e-03 | NA |
2. P | P01909 | HLA class II histocompatibility antigen, DQ alpha 1 chain | 1.29e-03 | 1.78e-07 | NA |
2. P | P18535 | Envelope glycoprotein C homolog | NA | 3.60e-08 | NA |
2. P | Q3U497 | CMRF35-like molecule 7 | 1.68e-01 | 4.81e-03 | NA |
2. P | A6NFU0 | Ig-like V-type domain-containing protein FAM187A | 1.02e-02 | 7.47e-04 | NA |
2. P | P11465 | Pregnancy-specific beta-1-glycoprotein 2 | 9.88e-05 | 1.14e-04 | NA |
2. P | Q9D780 | SLAM family member 9 | 6.54e-03 | 2.33e-11 | NA |
2. P | Q3T113 | Transmembrane and immunoglobulin domain-containing protein 1 | 1.46e-04 | 9.58e-06 | NA |
2. P | A0A0E4BZH1 | Selection and upkeep of intraepithelial T-cells protein 1 | 8.22e-04 | 1.95e-03 | NA |
2. P | Q0IJ12 | V-set and transmembrane domain-containing protein 2B | 2.27e-02 | 2.22e-02 | NA |
2. P | Q64JA4 | Sialic acid-binding Ig-like lectin 13 | 9.05e-07 | 3.38e-09 | NA |
2. P | Q8MJZ2 | Leukocyte immunoglobulin-like receptor subfamily A member 6 | 1.59e-03 | 5.50e-05 | NA |
2. P | Q9Z0M4 | Membrane cofactor protein | 1.51e-01 | 1.67e-02 | NA |
2. P | Q6PI73 | Leukocyte immunoglobulin-like receptor subfamily A member 6 | 1.20e-03 | 7.68e-06 | NA |
2. P | Q8BLK3 | Limbic system-associated membrane protein | 4.37e-05 | 2.92e-02 | NA |
2. P | Q95132 | Intercellular adhesion molecule 1 | 8.74e-05 | 1.42e-06 | NA |
2. P | P27645 | Low affinity immunoglobulin gamma Fc region receptor III | 2.64e-02 | 4.32e-11 | NA |
2. P | P59901 | Leukocyte immunoglobulin-like receptor subfamily A member 4 | 4.67e-04 | 1.00e-05 | NA |
2. P | P33706 | T-cell surface glycoprotein CD8 alpha chain | 3.06e-02 | 5.91e-07 | NA |
2. P | Q61826 | Mucosal addressin cell adhesion molecule 1 | 3.43e-04 | 2.85e-04 | NA |
2. P | P17790 | Basigin | 4.11e-03 | 2.42e-09 | NA |
2. P | Q98892 | Opioid-binding protein/cell adhesion molecule homolog | 4.08e-07 | 9.91e-06 | NA |
2. P | P03173 | Envelope glycoprotein C | NA | 5.88e-14 | NA |
2. P | B0CLX4 | V-set and immunoglobulin domain-containing protein 10 | 9.87e-06 | 1.17e-02 | NA |
2. P | Q9JF44 | Protein B5 | NA | 2.71e-04 | NA |
2. P | O95998 | Interleukin-18-binding protein | 2.26e-02 | 4.79e-02 | NA |
2. P | Q08708 | CMRF35-like molecule 6 | 7.56e-03 | 3.77e-04 | NA |
2. P | W5XKT8 | Sperm acrosome membrane-associated protein 6 | 6.44e-02 | 1.60e-03 | NA |
2. P | P0C6N0 | Secreted protein BARF1 | NA | 9.98e-07 | NA |
2. P | Q9XT56 | Junctional adhesion molecule A | 8.04e-04 | 8.68e-08 | NA |
2. P | Q8CIQ3 | Beta-2-microglobulin | 1.51e-04 | 2.12e-02 | NA |
2. P | Q62813 | Limbic system-associated membrane protein | 5.42e-06 | 8.36e-08 | NA |
2. P | Q7TSN2 | CMRF-35-like molecule 4 | 9.39e-03 | 4.49e-03 | NA |
2. P | Q96IQ7 | V-set and immunoglobulin domain-containing protein 2 | 7.71e-05 | 4.86e-04 | NA |
2. P | P79107 | Low affinity immunoglobulin gamma Fc region receptor III | 1.68e-03 | 8.57e-08 | NA |
2. P | Q8R0A6 | V-set and transmembrane domain-containing protein 2A | 3.95e-02 | 1.05e-03 | NA |
2. P | P28078 | Class II histocompatibility antigen, M alpha chain | 4.58e-03 | 1.18e-04 | NA |
2. P | A6NI73 | Leukocyte immunoglobulin-like receptor subfamily A member 5 | 2.17e-03 | 1.41e-09 | NA |
2. P | Q80Z24 | Neuronal growth regulator 1 | 2.15e-06 | 5.56e-10 | NA |
2. P | Q9JK39 | Butyrophilin-like protein 10 | 6.34e-05 | 1.09e-07 | NA |
2. P | Q08ET2 | Sialic acid-binding Ig-like lectin 14 | 4.55e-05 | 2.35e-10 | NA |
2. P | P24084 | Protein B5 | NA | 3.16e-03 | NA |
2. P | A0A0K2S4Q6 | Protein CD300H | 4.97e-02 | 4.53e-02 | NA |
2. P | Q00888 | Pregnancy-specific beta-1-glycoprotein 4 | 3.55e-03 | 5.86e-03 | NA |
2. P | P18627 | Lymphocyte activation gene 3 protein | 2.51e-03 | 8.81e-09 | NA |
2. P | Q6TYI6 | Triggering receptor expressed on myeloid cells 1 | 2.80e-03 | 3.00e-06 | NA |
2. P | P22650 | Envelope glycoprotein C homolog | NA | 2.62e-05 | NA |
2. P | Q8TAG5 | V-set and transmembrane domain-containing protein 2A | 3.43e-02 | 7.31e-04 | NA |
2. P | P79185 | T-cell surface glycoprotein CD4 | 5.16e-04 | 2.01e-03 | NA |
2. P | A1YIY0 | Fc receptor-like protein 6 | 2.31e-03 | 4.70e-05 | NA |
2. P | P22596 | Envelope glycoprotein C | NA | 3.77e-10 | NA |
2. P | D3YZF7 | V-set and immunoglobulin domain-containing protein 10-like | 1.39e-02 | 1.52e-03 | NA |
2. P | Q5NKV9 | Intercellular adhesion molecule 1 | 6.25e-05 | 1.07e-05 | NA |
2. P | A2A7V7 | CMRF35-like molecule 6 | 3.13e-02 | 1.97e-02 | NA |
2. P | Q6VE48 | Membrane cofactor protein | 1.18e-01 | 8.32e-07 | NA |
2. P | P20037 | Rano class II histocompatibility antigen, B alpha chain | 3.61e-03 | 8.43e-06 | NA |
2. P | Q08336 | T-cell surface glycoprotein CD4 (Fragment) | 9.58e-04 | 1.74e-03 | NA |
2. P | Q07717 | Beta-2-microglobulin | 3.84e-04 | 2.38e-02 | NA |
2. P | A3RFZ7 | Low affinity immunoglobulin gamma Fc region receptor III | 1.95e-02 | 5.36e-07 | NA |
2. P | P70105 | Membrane cofactor protein | 1.59e-01 | 4.41e-02 | NA |
2. P | G5EEY6 | Zwei Ig domain protein zig-3 | 6.07e-03 | 4.71e-03 | NA |
2. P | Q6PZD2 | Tapasin | 6.81e-04 | 1.58e-02 | NA |
2. P | Q14954 | Killer cell immunoglobulin-like receptor 2DS1 | 1.06e-02 | 6.42e-05 | NA |
2. P | Q2YHT7 | Cell surface glycoprotein CD200 receptor 1-A | 1.18e-02 | 5.42e-08 | NA |
2. P | A7E3C4 | Ig-like V-type domain-containing protein FAM187A | 7.05e-03 | 5.63e-03 | NA |
2. P | P31783 | T-cell surface glycoprotein CD8 alpha chain | 1.65e-02 | 1.59e-03 | NA |
2. P | Q5R412 | Neuronal growth regulator 1 | 8.13e-06 | 5.12e-10 | NA |
2. P | Q6ZMC9 | Sialic acid-binding Ig-like lectin 15 | 1.11e-02 | 6.01e-08 | NA |
2. P | P01904 | H-2 class II histocompatibility antigen, E-D alpha chain | 1.12e-03 | 1.32e-05 | NA |
2. P | Q5UKY4 | Cell surface glycoprotein CD200 receptor 3 | 1.12e-02 | 1.32e-06 | NA |
2. P | Q89730 | Envelope glycoprotein C | NA | 3.19e-12 | NA |
2. P | P15981 | SLA class II histocompatibility antigen, DQ haplotype D alpha chain | 1.01e-02 | 7.72e-09 | NA |
2. P | Q8BTP3 | Cell surface glycoprotein CD200 receptor 5 | 8.53e-04 | 2.25e-13 | NA |
2. P | Q01227 | Protein B5 | NA | 1.69e-03 | NA |
2. P | P23068 | Class II histocompatibility antigen, B-L beta chain (Fragment) | 5.80e-03 | 9.28e-07 | NA |
2. P | P20352 | Tissue factor | 8.72e-02 | 6.40e-03 | NA |
2. P | Q6S6Q5 | Envelope glycoprotein C | NA | 2.62e-13 | NA |
2. P | Q07699 | Sodium channel subunit beta-1 | 6.97e-02 | 6.28e-03 | NA |
2. P | Q9MYX7 | Cytotoxic T-lymphocyte protein 4 | 3.98e-02 | 5.99e-04 | NA |
2. P | O70540 | Mucosal addressin cell adhesion molecule 1 | 1.18e-03 | 2.83e-03 | NA |
2. P | P14426 | H-2 class I histocompatibility antigen, D-K alpha chain | 6.41e-03 | 7.18e-08 | NA |
2. P | Q8SPW2 | Low affinity immunoglobulin gamma Fc region receptor III | 2.63e-02 | 3.94e-07 | NA |
2. P | A5D7V5 | Cell surface glycoprotein CD200 receptor 1 | 7.99e-03 | 6.26e-11 | NA |
2. P | P16721 | Protein UL11 | NA | 3.86e-03 | NA |
2. P | Q9D3R5 | Ig-like V-type domain-containing protein FAM187A | 1.52e-02 | 1.02e-02 | NA |
2. P | P01902 | H-2 class I histocompatibility antigen, K-D alpha chain | 9.41e-03 | 1.59e-07 | NA |
2. P | Q14953 | Killer cell immunoglobulin-like receptor 2DS5 | 8.06e-04 | 5.95e-06 | NA |
2. P | P42071 | T-lymphocyte activation antigen CD86 | 1.70e-03 | 3.28e-04 | NA |
2. P | P24083 | Plaque-size/host range protein | NA | 9.39e-04 | NA |
2. P | O43699 | Sialic acid-binding Ig-like lectin 6 | 7.81e-06 | 2.64e-03 | NA |
2. P | Q98919 | Limbic system-associated membrane protein | 4.85e-06 | 2.72e-07 | NA |
2. P | Q5NKV6 | Intercellular adhesion molecule 1 | 3.82e-05 | 4.19e-07 | NA |
2. P | P79336 | T-cell surface glycoprotein CD8 beta chain | 5.26e-02 | 3.50e-03 | NA |
2. P | P01731 | T-cell surface glycoprotein CD8 alpha chain | 2.71e-02 | 2.07e-04 | NA |
2. P | P01906 | HLA class II histocompatibility antigen, DQ alpha 2 chain | 2.71e-03 | 1.41e-08 | NA |
2. P | Q5T2D2 | Trem-like transcript 2 protein | 2.21e-02 | 3.12e-02 | NA |
2. P | Q9ERM2 | Intercellular adhesion molecule 4 | 8.86e-04 | 1.42e-13 | NA |
2. P | P0C788 | OX-2 membrane glycoprotein homolog | NA | 1.98e-16 | NA |
2. P | P35330 | Intercellular adhesion molecule 2 | 1.29e-04 | 1.24e-02 | NA |
2. P | A0A0B4J1G0 | Low affinity immunoglobulin gamma Fc region receptor IV | 2.83e-03 | 2.46e-06 | NA |
2. P | P79138 | Membrane cofactor protein | 2.24e-01 | 1.02e-03 | NA |
2. P | G5ED00 | Zwei Ig domain protein zig-8 | 8.78e-04 | 1.15e-07 | NA |
2. P | P33705 | T-cell surface glycoprotein CD4 | 4.41e-04 | 8.82e-04 | NA |
2. P | Q2TBX5 | Translocon-associated protein subunit delta | 2.99e-02 | 1.14e-02 | NA |
2. P | Q95JB9 | Natural cytotoxicity triggering receptor 1 | 4.74e-03 | 8.12e-04 | NA |
2. P | Q9NQ25 | SLAM family member 7 | 4.74e-03 | 1.89e-02 | NA |
2. P | Q96A28 | SLAM family member 9 | 6.29e-03 | 1.31e-05 | NA |
2. P | P30434 | T-cell surface glycoprotein CD8 beta chain | 7.54e-03 | 4.46e-04 | NA |
2. P | Q8K4F0 | CD226 antigen | 2.38e-03 | 2.85e-04 | NA |
2. P | Q8HW98 | IgLON family member 5 | 1.57e-05 | 6.57e-08 | NA |
2. P | P10228 | Envelope glycoprotein C | NA | 7.42e-03 | NA |
2. P | Q9JHY1 | Junctional adhesion molecule A | 1.14e-03 | 2.80e-09 | NA |
2. P | P32736 | Opioid-binding protein/cell adhesion molecule | 2.09e-05 | 1.33e-07 | NA |
2. P | Q6MG56 | Lymphocyte antigen 6 complex locus protein G6f | 1.11e-03 | 1.59e-03 | NA |
2. P | Q18806 | Neuronal immunoglobulin domain-containing protein rig-3 | 2.35e-03 | 3.76e-02 | NA |
2. P | P11464 | Pregnancy-specific beta-1-glycoprotein 1 | 5.65e-03 | 4.29e-02 | NA |
2. P | P14437 | H-2 class II histocompatibility antigen, A-S alpha chain | 3.69e-03 | 8.51e-03 | NA |
2. P | Q9BD50 | Major histocompatibility complex class I-related gene protein | 1.46e-02 | 1.96e-04 | NA |
2. P | Q68EV1 | CD276 antigen homolog | 4.72e-05 | 2.30e-11 | NA |
2. P | Q91Y57 | Sialic acid-binding Ig-like lectin 12 | 8.73e-07 | 1.52e-02 | NA |
2. P | O15533 | Tapasin | 1.49e-03 | 3.53e-02 | NA |
2. P | Q6XJV6 | Cell surface glycoprotein CD200 receptor 2 | 1.32e-03 | 2.22e-19 | NA |
2. P | P14434 | H-2 class II histocompatibility antigen, A-B alpha chain | 1.89e-03 | 5.05e-09 | NA |
2. P | Q00954 | Sodium channel subunit beta-1 | 5.95e-02 | 7.16e-04 | NA |
2. P | Q62718 | Neurotrimin | 4.29e-05 | 7.00e-08 | NA |
2. P | P22651 | Envelope glycoprotein C homolog | NA | 2.05e-04 | NA |
2. P | Q5REH6 | Translocon-associated protein subunit delta | 4.45e-02 | 3.56e-02 | NA |
2. P | Q5SQ64 | Lymphocyte antigen 6 complex locus protein G6f | 1.09e-03 | 5.78e-08 | NA |
2. P | P33865 | 36 kDa major membrane protein F5 | NA | 6.73e-03 | NA |
2. P | Q99NH8 | Triggering receptor expressed on myeloid cells 2 | 8.00e-02 | 1.62e-02 | NA |
2. P | Q14982 | Opioid-binding protein/cell adhesion molecule | 9.74e-06 | 1.83e-08 | NA |
2. P | P51571 | Translocon-associated protein subunit delta | 4.31e-02 | 3.56e-02 | NA |
2. P | P06024 | Envelope glycoprotein C homolog | NA | 2.97e-06 | NA |
2. P | B6A8C7 | T-cell-interacting, activating receptor on myeloid cells protein 1 | 4.93e-04 | 1.06e-09 | NA |
2. P | Q00887 | Pregnancy-specific beta-1-glycoprotein 9 | 1.19e-03 | 1.07e-03 | NA |
2. P | P12371 | High affinity immunoglobulin epsilon receptor subunit alpha | 2.53e-03 | 2.45e-05 | NA |
2. P | O54901 | OX-2 membrane glycoprotein | 1.33e-06 | 4.00e-15 | NA |
2. P | Q6AXV7 | Ig-like V-type domain-containing protein FAM187A | 1.44e-02 | 7.35e-03 | NA |
2. P | P24071 | Immunoglobulin alpha Fc receptor | 1.57e-02 | 3.38e-06 | NA |
2. P | Q9UKJ0 | Paired immunoglobulin-like type 2 receptor beta | 1.07e-02 | 8.26e-03 | NA |
2. P | Q2KI11 | Sodium channel subunit beta-3 | 4.34e-02 | 1.38e-02 | NA |
2. P | Q9Z0J8 | Neuronal growth regulator 1 | 1.42e-05 | 7.52e-10 | NA |
2. P | Q7TNR6 | Immunoglobulin superfamily member 21 | 1.84e-04 | 2.54e-02 | NA |
2. P | P41688 | T-cell surface glycoprotein CD8 alpha chain | 4.20e-02 | 6.30e-06 | NA |
2. P | P11609 | Antigen-presenting glycoprotein CD1d1 | 2.62e-03 | 1.46e-02 | NA |
2. P | P14435 | H-2 class II histocompatibility antigen, A-F alpha chain | 3.59e-03 | 4.44e-03 | NA |
2. P | P10966 | T-cell surface glycoprotein CD8 beta chain | 9.48e-03 | 7.25e-05 | NA |
2. P | Q9Y624 | Junctional adhesion molecule A | 1.06e-03 | 3.04e-05 | NA |
2. P | Q24372 | Lachesin | 3.00e-06 | 7.77e-14 | NA |
2. P | Q9EP73 | Programmed cell death 1 ligand 1 | 9.36e-06 | 1.20e-11 | NA |
2. P | Q8BHK2 | Sodium channel subunit beta-3 | 1.95e-02 | 4.09e-02 | NA |
2. P | P28986 | Envelope glycoprotein C | NA | 3.94e-03 | NA |
2. P | Q63203 | Low affinity immunoglobulin gamma Fc region receptor II | 1.50e-02 | 9.14e-05 | NA |
2. P | P20747 | Putative Ig-like domain-containing protein ORF10 | NA | 2.29e-05 | NA |
2. P | Q6Q8B3 | Cell surface glycoprotein CD200 receptor 2 | 1.29e-03 | 5.81e-18 | NA |
2. P | Q5IS61 | Opioid-binding protein/cell adhesion molecule | 9.73e-06 | 1.83e-08 | NA |
2. P | Q96ID5 | Immunoglobulin superfamily member 21 | 1.86e-04 | 2.16e-02 | NA |
2. P | P10300 | T-cell surface glycoprotein CD8 beta chain | 1.61e-02 | 1.15e-02 | NA |
2. P | Q9JLM2 | Natural killer cell receptor 2B4 | 2.14e-03 | 3.27e-02 | NA |
2. P | Q63493 | Antigen-presenting glycoprotein CD1d | 1.92e-02 | 1.51e-03 | NA |
2. P | O57254 | Protein B5 | NA | 3.69e-04 | NA |
2. P | P21115 | Protein B5 | NA | 9.39e-04 | NA |
2. P | Q62151 | Advanced glycosylation end product-specific receptor | 2.24e-05 | 1.05e-05 | NA |
2. P | Q6UXZ3 | CMRF35-like molecule 5 | 6.75e-03 | 6.35e-05 | NA |
2. P | P13688 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 3.24e-04 | 1.24e-04 | NA |
2. P | Q9UQ72 | Pregnancy-specific beta-1-glycoprotein 11 | 4.89e-05 | 1.87e-02 | NA |
2. P | C1ITJ8 | Major histocompatibility complex class I-related gene protein | 1.50e-02 | 3.32e-04 | NA |
2. P | Q9JKA5 | Cell surface A33 antigen | 2.53e-04 | 9.36e-06 | NA |
2. P | P43631 | Killer cell immunoglobulin-like receptor 2DS2 | 1.38e-02 | 4.20e-05 | NA |
2. P | Q9ET39 | SLAM family member 6 | 7.67e-03 | 1.14e-04 | NA |
2. P | P26453 | Basigin | 1.14e-03 | 1.75e-09 | NA |
2. P | Q30631 | Mamu class II histocompatibility antigen, DR alpha chain | 6.07e-04 | 1.89e-06 | NA |
2. P | Q5R8H1 | Tapasin-related protein | 3.13e-03 | 2.64e-03 | NA |
2. P | Q14952 | Killer cell immunoglobulin-like receptor 2DS3 | 1.31e-02 | 8.20e-04 | NA |
2. P | P06332 | T-cell surface glycoprotein CD4 | 1.20e-03 | 2.78e-03 | NA |
2. P | Q14002 | Carcinoembryonic antigen-related cell adhesion molecule 7 | 3.36e-04 | 6.44e-13 | NA |
2. P | P42081 | T-lymphocyte activation antigen CD86 | 2.24e-03 | 6.09e-06 | NA |
2. P | Q496F6 | CMRF35-like molecule 2 | 2.56e-02 | 5.54e-06 | NA |
2. P | P08560 | Glycoprotein UL18 | NA | 4.09e-08 | NA |
2. P | Q2WGK2 | Junctional adhesion molecule A | 8.09e-04 | 1.24e-07 | NA |
2. P | Q08339 | T-cell surface glycoprotein CD4 (Fragment) | 5.40e-04 | 1.32e-03 | NA |
2. P | Q9XS78 | T-cell surface glycoprotein CD4 | 9.78e-04 | 1.54e-04 | NA |
2. P | P31995 | Low affinity immunoglobulin gamma Fc region receptor II-c | 4.74e-03 | 6.45e-04 | NA |
2. P | Q8R366 | Immunoglobulin superfamily member 8 | 6.53e-03 | 6.57e-08 | NA |
2. P | Q9P0V8 | SLAM family member 8 | 2.20e-03 | 1.90e-07 | NA |
2. P | O88792 | Junctional adhesion molecule A | 6.24e-04 | 6.16e-06 | NA |
2. P | Q8N149 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 2.25e-03 | 4.48e-09 | NA |
2. P | Q6SWB7 | Uncharacterized protein UL14 | NA | 7.27e-03 | NA |
2. P | P97300 | Neuroplastin | 5.51e-04 | 4.48e-09 | NA |
2. P | Q9BQ51 | Programmed cell death 1 ligand 2 | 5.37e-05 | 2.26e-11 | NA |
2. P | P32942 | Intercellular adhesion molecule 3 | 9.84e-04 | 5.52e-03 | NA |
3. B | O70355 | Butyrophilin-like protein 2 | 7.30e-07 | NA | 2.41e-04 |
3. B | Q86XK7 | V-set and immunoglobulin domain-containing protein 1 | 1.78e-04 | NA | 3.24e-06 |
3. B | P01696 | Ig kappa chain V region K29-213 | 2.24e-04 | NA | 0.006 |
3. B | P23087 | Ig heavy chain C region, secreted form (Fragment) | 1.59e-04 | NA | 2.67e-04 |
3. B | Q07409 | Contactin-3 | 4.89e-02 | NA | 0.029 |
3. B | P20760 | Ig gamma-2A chain C region | 1.88e-07 | NA | 1.35e-04 |
3. B | O95428 | Papilin | 1.70e-01 | NA | 0.006 |
3. B | O42414 | Neurofascin | 1.57e-01 | NA | 0.029 |
3. B | P01864 | Ig gamma-2A chain C region secreted form | 2.40e-07 | NA | 0.042 |
3. B | Q3ZCH5 | Zinc-alpha-2-glycoprotein | 1.35e-02 | NA | 0.011 |
3. B | P0DOX6 | Immunoglobulin mu heavy chain | 4.07e-06 | NA | 0.015 |
3. B | P14429 | H-2 class I histocompatibility antigen, Q7 alpha chain | 8.32e-03 | NA | 0.043 |
3. B | A0A0K0K1D8 | T cell receptor beta variable 6-1 | 5.13e-03 | NA | 0.028 |
3. B | P01860 | Immunoglobulin heavy constant gamma 3 | 6.96e-06 | NA | 5.21e-04 |
3. B | P0DP09 | Immunoglobulin kappa variable 1-13 | 7.78e-03 | NA | 0.008 |
3. B | Q9H106 | Signal-regulatory protein delta | 2.02e-06 | NA | 1.99e-32 |
3. B | Q9D2J4 | V-set and immunoglobulin domain-containing protein 1 | 2.55e-03 | NA | 7.68e-05 |
3. B | Q9P232 | Contactin-3 | 3.23e-02 | NA | 0.028 |
3. B | Q967D7 | Protein turtle | 1.96e-02 | NA | 0.002 |
3. B | P01637 | Ig kappa chain V-V region T1 | 1.21e-03 | NA | 0.019 |
3. B | P01872 | Immunoglobulin heavy constant mu | 2.80e-04 | NA | 0.024 |
3. B | Q8VIM0 | Hepatitis A virus cellular receptor 2 homolog | 1.80e-02 | NA | 0.047 |
3. B | P0DOX8 | Immunoglobulin lambda-1 light chain | 1.94e-06 | NA | 0.004 |
3. B | P01694 | Ig kappa chain V region 3547 | 2.74e-04 | NA | 0.028 |
3. B | P15978 | Class I histocompatibility antigen, Non-RT1.A alpha-1 chain | 3.46e-02 | NA | 0.010 |
3. B | P06336 | Ig epsilon chain C region | 6.53e-05 | NA | 0.050 |
3. B | P04433 | Immunoglobulin kappa variable 3-11 | 1.15e-02 | NA | 0.013 |
3. B | P01635 | Ig kappa chain V-V region K2 (Fragment) | 3.81e-04 | NA | 0.005 |
3. B | Q9U3P2 | Synaptogenesis protein syg-2 | 3.28e-04 | NA | 0.008 |
3. B | P0DPF4 | T cell receptor alpha variable 35 | 4.81e-04 | NA | 0.015 |
3. B | P06337 | Ig mu chain C region | 2.02e-04 | NA | 0.003 |
3. B | P01619 | Immunoglobulin kappa variable 3-20 | 8.33e-04 | NA | 1.42e-04 |
3. B | Q9UPX0 | Protein turtle homolog B | 2.83e-02 | NA | 0.015 |
3. B | P0DOX5 | Immunoglobulin gamma-1 heavy chain | 1.16e-06 | NA | 3.23e-04 |
3. B | A0A0B4J274 | T cell receptor alpha variable 20 | 1.31e-03 | NA | 0.021 |
3. B | P01847 | Ig lambda chain C region | 5.95e-05 | NA | 0.010 |
3. B | O95727 | Cytotoxic and regulatory T-cell molecule | 6.64e-05 | NA | 0.001 |
3. B | Q63678 | Zinc-alpha-2-glycoprotein | 1.05e-02 | NA | 5.44e-05 |
3. B | P03988 | Ig mu chain C region secreted form | 2.73e-04 | NA | 6.32e-05 |
3. B | O60500 | Nephrin | 3.11e-03 | NA | 1.85e-04 |
3. B | P01920 | HLA class II histocompatibility antigen, DQ beta 1 chain | 1.01e-02 | NA | 0.005 |
3. B | A4IGL7 | Peroxidasin | 3.64e-02 | NA | 0.005 |
3. B | Q62230 | Sialoadhesin | 6.68e-02 | NA | 0.005 |
3. B | P25311 | Zinc-alpha-2-glycoprotein | 8.49e-03 | NA | 2.27e-04 |
3. B | B7Z8K6 | T cell receptor delta constant | 5.28e-03 | NA | 6.80e-04 |
3. B | P15983 | SLA class II histocompatibility antigen, DQ haplotype D beta chain | 1.09e-02 | NA | 6.22e-05 |
3. B | P01868 | Ig gamma-1 chain C region secreted form | 2.69e-06 | NA | 0.004 |
3. B | Q96RW7 | Hemicentin-1 | NA | NA | 0.024 |
3. B | P97603 | Neogenin (Fragment) | 7.72e-02 | NA | 0.009 |
3. B | P23086 | Ig heavy chain C region (Fragment) | 8.18e-05 | NA | 5.71e-04 |
3. B | P97798 | Neogenin | 1.10e-01 | NA | 0.033 |
3. B | A0A0A0MRZ8 | Immunoglobulin kappa variable 3D-11 | 2.93e-04 | NA | 0.027 |
3. B | Q8AYH8 | Beta-2-microglobulin | 2.33e-04 | NA | 0.002 |
3. B | P01651 | Ig kappa chain V-V region EPC 109 | 3.50e-04 | NA | 0.013 |
3. B | P01822 | Ig heavy chain V region MOPC 315 | 5.64e-05 | NA | 0.012 |
3. B | P01863 | Ig gamma-2A chain C region, A allele | 3.61e-06 | NA | 0.002 |
3. B | P01618 | Ig kappa chain V region GOM | 5.35e-04 | NA | 0.002 |
3. B | P01682 | Ig kappa chain V region 2717 | NA | NA | 0.033 |
3. B | B1Q236 | Synaptogenesis protein syg-1 | 4.88e-04 | NA | 1.10e-05 |
3. B | P0DOX4 | Immunoglobulin epsilon heavy chain | 2.00e-06 | NA | 0.021 |
3. B | P01836 | Ig kappa chain C region, A allele | 7.59e-05 | NA | 0.003 |
3. B | Q9EPF2 | Cell surface glycoprotein MUC18 | 2.66e-04 | NA | 0.006 |
3. B | A0A0B4J2D9 | Immunoglobulin kappa variable 1D-13 | 4.42e-04 | NA | 0.008 |
3. B | P43121 | Cell surface glycoprotein MUC18 | 9.23e-05 | NA | 2.07e-04 |
3. B | P01650 | Ig kappa chain V-V region UPC 61 | 3.21e-04 | NA | 0.004 |
3. B | P01652 | Ig kappa chain V-V region J606 | 3.17e-04 | NA | 0.002 |
3. B | O94856 | Neurofascin | 7.42e-02 | NA | 0.001 |
3. B | P14428 | H-2 class I histocompatibility antigen, K-Q alpha chain (Fragment) | 2.79e-02 | NA | 0.012 |
3. B | Q7Z553 | MAM domain-containing glycosylphosphatidylinositol anchor protein 2 | 6.36e-03 | NA | 0.033 |
3. B | P20767 | Ig lambda-2 chain C region | 2.46e-04 | NA | 0.028 |
3. B | Q810U3 | Neurofascin | 1.26e-01 | NA | 0.005 |
3. B | Q8NDA2 | Hemicentin-2 | NA | NA | 0.017 |
3. B | P0DOX7 | Immunoglobulin kappa light chain | 6.68e-07 | NA | 8.42e-08 |
3. B | P01857 | Immunoglobulin heavy constant gamma 1 | 1.52e-05 | NA | 1.69e-04 |
3. B | P01643 | Ig kappa chain V-V region MOPC 173 | NA | NA | 0.002 |
3. B | P01862 | Ig gamma-2 chain C region | NA | NA | 0.003 |
3. B | O73895 | Tapasin | 1.24e-05 | NA | 6.09e-04 |
3. B | P01859 | Immunoglobulin heavy constant gamma 2 | 1.81e-05 | NA | 2.02e-04 |
3. B | A0A0C4DH25 | Immunoglobulin kappa variable 3D-20 | 1.72e-02 | NA | 1.50e-04 |
3. B | P20761 | Ig gamma-2B chain C region | 4.16e-07 | NA | 1.36e-05 |
3. B | P01895 | H-2 class I histocompatibility antigen, alpha chain (Fragment) | 1.08e-03 | NA | 0.004 |
3. B | Q0PMG2 | MAM domain-containing glycosylphosphatidylinositol anchor protein 1 | 2.15e-02 | NA | 0.004 |
3. B | P01896 | H-2 class I histocompatibility antigen, alpha chain (Fragment) | 2.12e-03 | NA | 0.006 |
3. B | A0A0B4J1U7 | Immunoglobulin heavy variable 6-1 | 1.35e-03 | NA | 0.011 |
3. B | Q9PWR4 | V-set and immunoglobulin domain-containing protein 1 | 2.28e-04 | NA | 5.89e-07 |
3. B | P20759 | Ig gamma-1 chain C region | 1.41e-07 | NA | 1.12e-04 |
3. B | P01854 | Immunoglobulin heavy constant epsilon | 1.11e-04 | NA | 0.016 |
3. B | P01835 | Ig kappa chain C region, B allele | 7.87e-05 | NA | 0.001 |
3. B | P01688 | Ig kappa chain V region K-25 | NA | NA | 0.019 |
3. B | P84751 | Ig heavy chain Mem5 (Fragment) | 1.75e-05 | NA | 0.003 |
3. B | P01636 | Ig kappa chain V-V region MOPC 149 | 4.04e-04 | NA | 5.57e-04 |
3. B | Q64726 | Zinc-alpha-2-glycoprotein | 1.50e-02 | NA | 0.004 |
3. B | P23085 | Ig heavy chain C region (Fragment) | 7.69e-05 | NA | 2.97e-04 |
3. B | P97685 | Neurofascin | 1.48e-01 | NA | 0.001 |
3. B | P35329 | B-cell receptor CD22 | 3.04e-04 | NA | 0.003 |
3. B | A0A075B6H7 | Probable non-functional immunoglobulin kappa variable 3-7 | 3.85e-04 | NA | 0.003 |
3. B | Q8WZ42 | Titin | NA | NA | 0.001 |
3. B | A0A0B4J275 | T cell receptor alpha variable 17 | 6.22e-03 | NA | 8.29e-06 |
3. B | P01879 | Ig alpha chain C region (Fragment) | 8.12e-04 | NA | 0.001 |
3. B | P23084 | Ig heavy chain C region (Fragment) | 8.88e-05 | NA | 0.020 |
3. B | P01691 | Ig kappa chain V region 12F2 (Fragment) | 1.34e-04 | NA | 5.35e-04 |
3. B | P01684 | Ig kappa chain V region 3374 | 1.78e-04 | NA | 0.006 |
3. B | P20762 | Ig gamma-2C chain C region | 1.28e-06 | NA | 0.002 |
3. B | Q5ZPR3 | CD276 antigen | 5.19e-07 | NA | 0.008 |
3. B | P01846 | Ig lambda chain C region | 7.75e-05 | NA | 0.007 |
3. B | Q9IA97 | Beta-2-microglobulin | 1.02e-04 | NA | 0.033 |
3. B | P01653 | Ig kappa chain V-V region W3082 | 3.41e-04 | NA | 0.006 |
3. B | P84750 | Ig kappa chain V region Mem5 (Fragment) | 2.49e-04 | NA | 0.015 |
3. B | P01683 | Ig kappa chain V region 3315 | 1.59e-04 | NA | 3.42e-04 |
3. B | A0A075B6S5 | Immunoglobulin kappa variable 1-27 | 4.02e-04 | NA | 0.004 |
3. B | P22648 | Fasciclin-2 | 4.83e-03 | NA | 0.045 |
3. B | P01837 | Immunoglobulin kappa constant | 7.57e-05 | NA | 0.026 |
3. B | Q9R044 | Nephrin | 4.95e-04 | NA | 5.18e-04 |
3. B | P01861 | Immunoglobulin heavy constant gamma 4 | 1.59e-05 | NA | 2.06e-04 |
3. B | A0A0C4DH55 | Immunoglobulin kappa variable 3D-7 | 6.66e-03 | NA | 0.005 |
3. B | Q6UXE8 | Butyrophilin-like protein 3 | 4.87e-04 | NA | 6.95e-04 |
3. B | Q96MS0 | Roundabout homolog 3 | 1.49e-01 | NA | 0.038 |
3. B | A2AJ76 | Hemicentin-2 | NA | NA | 0.004 |
3. B | Q6UX41 | Butyrophilin-like protein 8 | 5.28e-04 | NA | 3.46e-05 |
3. B | A2ASS6 | Titin | NA | NA | 0.049 |
3. B | Q62682 | Contactin-3 | 1.05e-01 | NA | 0.039 |
3. B | P01870 | Ig gamma chain C region | 5.04e-06 | NA | 0.002 |
3. B | Q29RR6 | V-set and immunoglobulin domain-containing protein 1 | 1.53e-03 | NA | 1.46e-07 |
3. B | Q5R7W8 | Butyrophilin subfamily 2 member A2 | 1.28e-02 | NA | 0.042 |